Potassium Chloride inactive ingredients by manufacturer
Wondering whether your Potassium Chloride has lactose, gluten, soy, a dye or gelatin in it? The medicine is the same, but the fillers, coatings and colors differ from one company to the next. This page shows what each Potassium Chloride product's FDA label lists, so you can find a version that leaves out what you avoid and ask your pharmacist for it by its NDC.
We have read the FDA labels of 262 of the 286 current Potassium Chloride products on the market today, from 78 companies listing it with the FDA, and lined them up side by side. 21 are still being read and will appear on a later visit. 3 labels have no inactive-ingredient list we could read, so those products cannot be compared.
Ask about your bottle
Is there something in your Potassium Chloride? Ask in plain words.
Name the company, strength or the NDC on your bottle and the ingredient you avoid. The answer comes only from the FDA labels on this page.
Answers are drawn from the FDA label data on this page and checked against it. They are not medical advice: confirm with your pharmacist before relying on them.
The short answer
Which Potassium Chloride products list lactose, a gluten source, soy, dyes or gelatin?
-
LactoseNo checked product
No checked Potassium Chloride product lists lactose.
-
Wheat or gluten sourceDiffers by manufacturer
4 of 262 checked products list a wheat or gluten source; 258 do not. See the products
Does not list it A-S Medication Solutions Actavis Adare Advagen Pharma Limited Advagen Pharma Ltd Advagen Pharma Ltd. Ajenat American Health Packaging Amneal Pharmaceuticals LLC Amneal Pharmaceuticals NY LLC Amneal Pharmaceuticals of New York Aphena Pharma Solutions - Tennessee Atlantic Biologicals Aurobindo AvKARE AvPAK B. Braun Medical Baxter Healthcare BluePoint Bluepoint BPI Bryant Ranch Prepack Camber Cardinal Health 107 Carwin Pharmaceutical Associates Coupler Direct_Rx Endo Epic Fresenius Kabi Genus Lifesciences Genus Lifesciences Inc. Glenmark Granules India Granules Pharmaceuticals Inc Granules Pharmaceuticals Inc. Guardian Drug Henry Schein Heritage Pharmaceuticals Inc. d/b/a Avet HF Acquisition Co LLC, DBA HealthFirst Hospira ICU Medical IPG Kesin Lupin Pharmaceuticals, Inc. Lupin Pharmaceuticals,Inc. Macleods Major Marlex Pharmaceuticals, Inc. Marlex Pharmaceuticals Inc Mylan NCS HealthCare of KY, LLC dba Vangard Northstar Rx Northwind Health Novel PAI Holdings, LLC dba PAI PD-Rx Preferred Proficient Rx Redpharm Drug Remedyrepack Rising Saptalis Slate Run Solco Healthcare Somerset Therapeutics St. Mary's Medical Park Pharmacy Strides Pharma Science Sun Tris Upsher-Smith Upsher-SmithLaboratories XLCare Zydus Zydus Lifesciences -
SoyDiffers by manufacturer
10 of 262 checked products list soy; 252 do not. See the products
Does not list it A-S Medication Solutions Actavis Adare Advagen Pharma Limited Advagen Pharma Ltd Advagen Pharma Ltd. Ajenat American Health Packaging Amneal Pharmaceuticals LLC Amneal Pharmaceuticals NY LLC Amneal Pharmaceuticals of New York ANI Aphena Pharma Solutions - Tennessee Atlantic Biologicals Aurobindo AvKARE AvPAK B. Braun Medical Baxter Healthcare BluePoint Bluepoint BPI Bryant Ranch Prepack Camber Cardinal Health 107 Carwin Pharmaceutical Associates Coupler Direct_Rx Endo Epic Fresenius Kabi Genus Lifesciences Genus Lifesciences Inc. Glenmark Granules India Granules Pharmaceuticals Inc Granules Pharmaceuticals Inc. Guardian Drug Henry Schein Heritage Pharmaceuticals Inc. d/b/a Avet HF Acquisition Co LLC, DBA HealthFirst Hospira ICU Medical IPG Kesin Lupin Pharmaceuticals, Inc. Lupin Pharmaceuticals,Inc. Macleods Major Marlex Pharmaceuticals, Inc. Marlex Pharmaceuticals Inc Mylan NCS HealthCare of KY, LLC dba Vangard Northstar Rx Northwind Health Novel PAI Holdings, LLC dba PAI PD-Rx Preferred Proficient Rx Redpharm Drug Remedyrepack Rising Saptalis Slate Run Solco Healthcare Somerset Therapeutics Strides Pharma Science Sun Tris Upsher-Smith Upsher-SmithLaboratories XLCare Zydus Zydus Lifesciences -
Synthetic dyesDiffers by manufacturer
115 of 262 checked products list synthetic dyes; 147 do not. See the products
Does not list it A-S Medication Solutions Actavis Adare Advagen Pharma Ltd Advagen Pharma Ltd. American Health Packaging Aphena Pharma Solutions - Tennessee Aurobindo AvKARE B. Braun Medical Baxter Healthcare BluePoint Bluepoint Bryant Ranch Prepack Camber Cardinal Health 107 Coupler Direct_Rx Epic Fresenius Kabi Granules India Granules Pharmaceuticals Inc Granules Pharmaceuticals Inc. Henry Schein HF Acquisition Co LLC, DBA HealthFirst Hospira ICU Medical Lupin Pharmaceuticals,Inc. Macleods Major Mylan NCS HealthCare of KY, LLC dba Vangard Northstar Rx Northwind Health PD-Rx Preferred Proficient Rx Redpharm Drug Remedyrepack Slate Run Solco Healthcare St. Mary's Medical Park Pharmacy Sun Upsher-Smith Upsher-SmithLaboratories XLCare Zydus Zydus LifesciencesLists it A-S Medication Solutions Actavis Adare Advagen Pharma Limited Ajenat American Health Packaging Amneal Pharmaceuticals LLC Amneal Pharmaceuticals NY LLC Amneal Pharmaceuticals of New York ANI Aphena Pharma Solutions - Tennessee Atlantic Biologicals Aurobindo AvKARE AvPAK BluePoint BPI Bryant Ranch Prepack Camber Cardinal Health 107 Carwin Pharmaceutical Associates Direct_Rx Endo Epic Genus Lifesciences Genus Lifesciences Inc. Glenmark Granules India Granules Pharmaceuticals Inc Granules Pharmaceuticals Inc. Guardian Drug Heritage Pharmaceuticals Inc. d/b/a Avet IPG Kesin Lupin Pharmaceuticals, Inc. Lupin Pharmaceuticals,Inc. Macleods Major Marlex Pharmaceuticals, Inc. Marlex Pharmaceuticals Inc NCS HealthCare of KY, LLC dba Vangard Northstar Rx Northwind Health Novel PAI Holdings, LLC dba PAI PD-Rx Remedyrepack Rising Saptalis Solco Healthcare Somerset Therapeutics Strides Pharma Science Sun Tris Upsher-Smith Zydus -
GelatinDiffers by manufacturer
28 of 262 checked products list gelatin; 234 do not. See the products
Does not list it A-S Medication Solutions Actavis Advagen Pharma Limited Advagen Pharma Ltd Advagen Pharma Ltd. Ajenat American Health Packaging Amneal Pharmaceuticals LLC Amneal Pharmaceuticals NY LLC ANI Aphena Pharma Solutions - Tennessee Atlantic Biologicals Aurobindo AvKARE AvPAK B. Braun Medical Baxter Healthcare BluePoint Bluepoint BPI Bryant Ranch Prepack Camber Cardinal Health 107 Carwin Pharmaceutical Associates Coupler Direct_Rx Endo Epic Fresenius Kabi Genus Lifesciences Genus Lifesciences Inc. Granules India Granules Pharmaceuticals Inc. Guardian Drug Henry Schein Heritage Pharmaceuticals Inc. d/b/a Avet HF Acquisition Co LLC, DBA HealthFirst Hospira ICU Medical IPG Kesin Lupin Pharmaceuticals,Inc. Macleods Major Marlex Pharmaceuticals, Inc. Marlex Pharmaceuticals Inc Mylan NCS HealthCare of KY, LLC dba Vangard Northstar Rx Northwind Health Novel PAI Holdings, LLC dba PAI PD-Rx Preferred Proficient Rx Redpharm Drug Remedyrepack Rising Saptalis Slate Run Solco Healthcare Somerset Therapeutics St. Mary's Medical Park Pharmacy Strides Pharma Science Sun Tris Upsher-Smith Upsher-SmithLaboratories XLCare Zydus Zydus LifesciencesLists it A-S Medication Solutions Adare American Health Packaging Amneal Pharmaceuticals of New York AvPAK BluePoint Bryant Ranch Prepack Glenmark Granules India Granules Pharmaceuticals Inc Lupin Pharmaceuticals, Inc. Major NCS HealthCare of KY, LLC dba Vangard Northstar Rx PD-Rx Remedyrepack Solco Healthcare Sun Zydus
Also listed by some products: Corn 3 of 262 Tartrazine 4 of 262 Titanium dioxide 94 of 262 Carmine or shellac 16 of 262 Alcohol 2 of 262 Propylene glycol 43 of 262 PEG or polysorbate 72 of 262
Find a version without it
Every current Potassium Chloride product and what its label lists
| Product | Lists | Inactive ingredients on the label |
|---|---|---|
| A-S Medication Solutions 21 products | ||
| 10 mEq extended-release capsuleNDC 50090-4734-09 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Propylene glycol |
Show 12 ingredientsETHYLCELLULOSE (10 MPA.S), ETHYLCELLULOSE (45 MPA.S), FD&C BLUE NO. 1, FD&C RED NO. 40, GELATIN, UNSPECIFIED, POTASSIUM HYDROXIDE, PROPYLENE GLYCOL, SHELLAC, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 750 mg extended-release capsuleNDC 50090-7469-00 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Propylene glycol |
Show 11 ingredientsAKA3, ETHYLCELLULOSE (20 MPA.S), FD&C BLUE NO. 1, GELATIN, HYDROXYPROPYL CELLULOSE (110000 WAMW), KI5, POVIDONE, UNSPECIFIED, PROPYLENE GLYCOL, SHELLAC, SODIUM HYDROXIDE, TITANIUM DIOXIDE |
| 10 mEq extended-release tabletNDC 50090-6635-00 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 9 ingredientsETHYLCELLULOSE, UNSPECIFIED, FERRIC OXIDE RED, FERRIC OXIDE YELLOW, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, STEARIC ACID, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 50090-6639-00 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsETHYLCELLULOSE, KI203, KI5, Magnesium Stearate, PARAFFIN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, SILICA, Talc, Titanium Dioxide, Triethyl Citrate |
| 750 mg extended-release tabletNDC 50090-6640-00 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsD&C Yellow No. 10, ETHYLCELLULOSE, UNSPECIFIED, FD&C Yellow No. 6, Magnesium Stearate, PARAFFIN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, Silicon Dioxide, Talc, Titanium Dioxide, Triethyl Citrate |
| 750 mg extended-release tabletNDC 50090-5335-00 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 7 ingredientsHYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 4000, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 50090-7378-00 | Soy Polyethylene glycol or polysorbate |
Show 8 ingredientsCI 77891, HYDROGENATED COTTONSEED OIL, HYDROXYPROPYLCELLULOSE, LECITHIN, SOYBEAN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, SILICA, TALC |
| 750 mg extended-release tabletNDC 50090-7379-00 | Soy Polyethylene glycol or polysorbate |
Show 8 ingredientsCI 77891, HYDROGENATED COTTONSEED OIL, HYDROXYPROPYL CELLULOSE, UNSPECIFIED, LECITHIN, SOYBEAN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, SILICA, TALC |
| 750 mg extended-release tabletNDC 50090-7639-00 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 9 ingredientsACID YELLOW 3, FD&C YELLOW NO. 6, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, SAND, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 50090-7640-00 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 9 ingredientsACID YELLOW 3, FD&C YELLOW NO. 6, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, SAND, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 50090-7748-00 | Polyethylene glycol or polysorbate |
Show 11 ingredientsCI 77891, MAGNESIUM STEARATE, PARAFFIN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ACETATE, POLYVINYL ALCOHOL, POVIDONE, SILICA, SODIUM LAURYL SULFATE, TALC, TRIETHYL CITRATE |
| 750 mg extended-release tabletNDC 50090-7749-00 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsMAGNESIUM STEARATE, PARAFFIN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ACETATE, POLYVINYL ALCOHOL, POVIDONE, SILICA, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 1500 mg extended-release tabletNDC 50090-3700-00 | Still being read | Not read yet |
| 1500 mg extended-release tabletNDC 50090-5665-00 | None of these listed |
Show 4 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE (20 MPA.S), MICROCRYSTALLINE CELLULOSE, TRIETHYL CITRATE |
| 1500 mg extended-release tabletNDC 50090-6253-00 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, MICROCRYSTALLINE CELLULOSE |
| 1500 mg extended-release tabletNDC 50090-6866-00 | None of these listed |
Show 3 ingredientscroscarmellose sodium, ethylcellulose (20 MPA.S), microcrystalline cellulose |
| 1500 mg extended-release tabletNDC 50090-6867-00 | None of these listed |
Show 3 ingredientscroscarmellose sodium, ethylcellulose (20 MPA.S), microcrystalline cellulose |
| 1500 mg extended-release tabletNDC 50090-7192-00 | None of these listed |
Show 5 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, HYDROXYPROPYL CELLULOSE (1600000 WAMW), MICROCRYSTALLINE CELLULOSE, TALC |
| 1500 mg extended-release tabletNDC 50090-7193-00 | None of these listed |
Show 5 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, HYDROXYPROPYL CELLULOSE (1600000 WAMW), MICROCRYSTALLINE CELLULOSE, TALC |
| 1500 mg extended-release tabletNDC 50090-7456-00 | None of these listed |
Show 6 ingredientsCELLULOSE, MICROCRYSTALLINE, CROSPOVIDONE (120 .MU.M), ETHYLCELLULOSE, HYDROXYPROPYL CELLULOSE, UNSPECIFIED, MAGNESIUM STEARATE, TALC |
| 1500 mg extended-release tabletNDC 50090-7616-00 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, MICROCRYSTALLINE CELLULOSE |
| Actavis Pharma, Inc. 2 products | ||
| 750 mg extended-release capsuleNDC 62037-0560-01 | Synthetic dyes Titanium dioxide |
Show 6 ingredientsETHYLCELLULOSES, FD&C BLUE NO. 1, FD&C RED NO. 40, SODIUM LAURYL SULFATE, TITANIUM DIOXIDE, TRIACETIN |
| 20 mEq extended-release tabletNDC 62037-0720-01 | None of these listed |
Show 4 ingredientsACETYLTRIBUTYL CITRATE, CELLULOSE, MICROCRYSTALLINE, CROSPOVIDONE, ETHYLCELLULOSE (10 MPA.S) |
| Adare Pharmaceuticals Inc 2 products | ||
| 600 mg capsuleNDC 59917-0102-00 | Titanium dioxide Gelatin |
Show 5 ingredientsETHYLCELLULOSES, GELATIN, MAGNESIUM STEARATE, SODIUM LAURYL SULFATE, TITANIUM DIOXIDE |
| 750 mg capsuleNDC 59917-0103-00 | Synthetic dyes Titanium dioxide Gelatin |
Show 8 ingredientsETHYLCELLULOSES, FD&C BLUE NO. 1, FD&C RED NO. 3, FERROSOFERRIC OXIDE, GELATIN, MAGNESIUM STEARATE, SODIUM LAURYL SULFATE, TITANIUM DIOXIDE |
| Advagen Pharma Limited 3 products | ||
| 1.5 g/1.58 g oral solutionNDC 72888-0024-07 | Synthetic dyes |
Show 4 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, SILICON DIOXIDE, SUCRALOSE |
| 20 mEq/15 mL oral solutionNDC 72888-0041-13 | Synthetic dyes Propylene glycol |
Show 9 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, PROPYLENE GLYCOL, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| 40 mEq/15 mL oral solutionNDC 72888-0042-13 | Synthetic dyes Propylene glycol |
Show 9 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, PROPYLENE GLYCOL, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| Advagen Pharma Ltd 3 products | ||
| 750 mg extended-release tabletNDC 72888-0075-00 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsMAGNESIUM STEARATE, PARAFFIN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ACETATE, POLYVINYL ALCOHOL, UNSPECIFIED, POVIDONE, UNSPECIFIED, SILICON DIOXIDE, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 1125 mg extended-release tabletNDC 72888-0201-00 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsMAGNESIUM STEARATE, PARAFFIN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ACETATE, POLYVINYL ALCOHOL, UNSPECIFIED, POVIDONE, UNSPECIFIED, SILICON DIOXIDE, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 1500 mg extended-release tabletNDC 72888-0076-01 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsMAGNESIUM STEARATE, PARAFFIN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ACETATE, POLYVINYL ALCOHOL, UNSPECIFIED, POVIDONE, UNSPECIFIED, SILICON DIOXIDE, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| Advagen Pharma Ltd. 3 products | ||
| 750 mg extended-release tabletNDC 72888-0097-00 | None of these listed |
Show 5 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, TALC, TRIACETIN |
| 1125 mg extended-release tabletNDC 72888-0098-00 | None of these listed |
Show 5 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, TALC, TRIACETIN |
| 1500 mg extended-release tabletNDC 72888-0099-00 | None of these listed |
Show 5 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, TALC, TRIACETIN |
| Ajenat Pharmaceuticals LLC 3 products | ||
| 1.5 g/1.58 g oral solutionNDC 82983-0403-10 | Synthetic dyes |
Show 5 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, ORANGE, SILICON DIOXIDE, SUCRALOSE |
| 20 mEq/15 mL oral solutionNDC 82983-0411-47 | Synthetic dyes Propylene glycol |
Show 9 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, PROPYLENE GLYCOL, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| 40 mEq/15 mL oral solutionNDC 82983-0412-47 | Synthetic dyes Propylene glycol |
Show 9 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, PROPYLENE GLYCOL, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| American Health Packaging 7 products | ||
| 750 mg extended-release capsuleNDC 60687-0653-01 | Synthetic dyes Titanium dioxide Gelatin |
Show 8 ingredientsETHYLCELLULOSE, UNSPECIFIED, FD&C BLUE NO. 1, FD&C RED NO. 3, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, MAGNESIUM STEARATE, SODIUM LAURYL SULFATE, TITANIUM DIOXIDE |
| 20 mEq extended-release tabletNDC 60687-0756-09 | None of these listed |
Show 4 ingredientsACETYLTRIBUTYL CITRATE, CROSPOVIDONE, UNSPECIFIED, ETHYLCELLULOSE (10 MPA.S), MICROCRYSTALLINE CELLULOSE |
| 750 mg extended-release tabletNDC 60687-0632-01 | None of these listed |
Show 5 ingredientsCROSPOVIDONE, DIETHYL PHTHALATE, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE |
| 750 mg extended-release tabletNDC 60687-0810-09 | Still being read | Not read yet |
| 1.5 g/1.58 g oral solutionNDC 60687-0855-27 | Synthetic dyes |
Show 4 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, SILICON DIOXIDE, SUCRALOSE |
| 1.5 g/15 mL oral solutionNDC 60687-0628-07 | Synthetic dyes Propylene glycol |
Show 10 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, ORANGE, PROPYLENE GLYCOL, PROPYLPARABEN, SODIUM CITRATE, UNSPECIFIED FORM, SUCRALOSE, WATER |
| 1.5 g/15 mL oral solutionNDC 60687-0884-07 | Synthetic dyes Propylene glycol |
Show 10 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, ORANGE, PROPYLENE GLYCOL, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| Amneal Pharmaceuticals LLC 1 product | ||
| 1.5 g/1.58 g oral solutionNDC 60219-1617-03 | Synthetic dyes |
Show 6 ingredientsACACIA, ALPHA-TOCOPHEROL, ANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, SILICON DIOXIDE, SUCRALOSE |
| Amneal Pharmaceuticals NY LLC 2 products | ||
| 1.5 g/15 mL oral solutionNDC 69238-1459-02 | Synthetic dyes Propylene glycol |
Show 9 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, PROPYLENE GLYCOL, PROPYLPARABEN, SODIUM CITRATE, SUCRALOSE, WATER |
| 3 g/15 mL oral solutionNDC 69238-1458-02 | Synthetic dyes Propylene glycol |
Show 9 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, PROPYLENE GLYCOL, PROPYLPARABEN, SODIUM CITRATE, SUCRALOSE, WATER |
| Amneal Pharmaceuticals of New York LLC 1 product | ||
| 750 mg extended-release capsuleNDC 53746-0542-01 | Synthetic dyes Titanium dioxide Gelatin |
Show 7 ingredientsETHYLCELLULOSES, FD&C BLUE NO. 1, FD&C RED NO. 40, GELATIN, SODIUM LAURYL SULFATE, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| ANI Pharmaceuticals, Inc. 1 product | ||
| 1.5 g/1.56 g oral solutionNDC 70954-0197-20 | Wheat or gluten source Synthetic dyes |
Show 6 ingredientsACACIA, ANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, MALTODEXTRIN, SILICON DIOXIDE, SUCRALOSE |
| Aphena Pharma Solutions - Tennessee, LLC 9 products | ||
| 750 mg extended-release tabletNDC 71610-0977-30 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsD&C YELLOW NO. 10 ALUMINUM LAKE, ETHYLCELLULOSES, FD&C YELLOW NO. 6, MAGNESIUM STEARATE, PARAFFIN, POLYETHYLENE GLYCOL 4000, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 750 mg extended-release tabletNDC 71610-0935-60 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsD&C YELLOW NO. 10, ETHYLCELLULOSE, UNSPECIFIED, FD&C YELLOW NO. 6, MAGNESIUM STEARATE, PARAFFIN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 750 mg extended-release tabletNDC 71610-0932-60 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsD&C YELLOW NO. 10, FD&C YELLOW NO. 6, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, POVIDONE, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 71610-0960-60 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsMAGNESIUM STEARATE, PARAFFIN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ACETATE, POLYVINYL ALCOHOL, UNSPECIFIED, POVIDONE, UNSPECIFIED, SILICON DIOXIDE, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 750 mg extended-release tabletNDC 71610-0945-30 | Soy Titanium dioxide Polyethylene glycol or polysorbate |
Show 8 ingredientsHYDROGENATED COTTONSEED OIL, HYDROXYPROPYL CELLULOSE, UNSPECIFIED, LECITHIN, SOYBEAN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 71610-0944-30 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 7 ingredientsHYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 4000, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 71610-0349-15 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 9 ingredientsD&C YELLOW NO. 10, FD&C YELLOW NO. 6, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 1500 mg extended-release tabletNDC 71610-0343-15 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE (20 MPA.S), MICROCRYSTALLINE CELLULOSE |
| 1500 mg extended-release tabletNDC 71610-0632-15 | Still being read | Not read yet |
| Atlantic Biologicals Corp. 3 products | ||
| 1500 mg extended-release tabletNDC 17856-1135-01 | Still being read | Not read yet |
| 1.5 g/15 mL oral solutionNDC 17856-0048-01 | Synthetic dyes Propylene glycol |
Show 10 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, ORANGE, PROPYLENE GLYCOL, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| 3 g/15 mL oral solutionNDC 17856-1458-01 | Synthetic dyes Propylene glycol |
Show 9 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, PROPYLENE GLYCOL, PROPYLPARABEN, SODIUM CITRATE, SUCRALOSE, WATER |
| Aurobindo Pharma Limited 7 products | ||
| 600 mg extended-release tabletNDC 65862-0986-01 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 8 ingredientsFERRIC OXIDE RED, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 4000, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 59651-0429-01 | None of these listed |
Show 7 ingredientsCROSPOVIDONE (120 .MU.M), ETHYLCELLULOSE (20 MPA.S), HYDROXYPROPYL CELLULOSE (20000 WAMW), MICROCRYSTALLINE CELLULOSE, SORBITAN MONOOLEATE, STEARIC ACID, TALC |
| 750 mg extended-release tabletNDC 65862-0987-01 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 7 ingredientsHYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 4000, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 1125 mg extended-release tabletNDC 59651-0430-01 | None of these listed |
Show 7 ingredientsCROSPOVIDONE (120 .MU.M), ETHYLCELLULOSE (20 MPA.S), HYDROXYPROPYL CELLULOSE (20000 WAMW), MICROCRYSTALLINE CELLULOSE, SORBITAN MONOOLEATE, STEARIC ACID, TALC |
| 1500 mg extended-release tabletNDC 59651-0431-01 | None of these listed |
Show 7 ingredientsCROSPOVIDONE (120 .MU.M), ETHYLCELLULOSE (20 MPA.S), HYDROXYPROPYL CELLULOSE (20000 WAMW), MICROCRYSTALLINE CELLULOSE, SORBITAN MONOOLEATE, STEARIC ACID, TALC |
| 20 mEq/15 mL oral solutionNDC 59651-0959-47 | Synthetic dyes Propylene glycol |
Show 10 ingredients.ALPHA.-TOCOPHEROL, DL-, ANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, PROPYLENE GLYCOL, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| 40 mEq/15 mL oral solutionNDC 59651-0960-47 | Synthetic dyes Propylene glycol |
Show 10 ingredients.ALPHA.-TOCOPHEROL, DL-, ANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, PROPYLENE GLYCOL, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| AvKARE 4 products | ||
| 750 mg extended-release capsuleNDC 42291-0679-50 | Synthetic dyes Titanium dioxide |
Show 6 ingredientsETHYLCELLULOSES, FD&C BLUE NO. 1, FD&C RED NO. 40, SODIUM LAURYL SULFATE, TITANIUM DIOXIDE, TRIACETIN |
| 750 mg extended-release tabletNDC 42291-0487-01 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsD&C YELLOW NO. 10 ALUMINUM LAKE, ETHYLCELLULOSES, FD&C YELLOW NO. 6, MAGNESIUM STEARATE, PARAFFIN, POLYETHYLENE GLYCOL 4000, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 750 mg extended-release tabletNDC 42291-0506-01 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 9 ingredientsD&C YELLOW NO. 10, FD&C YELLOW NO. 6, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 1500 mg extended-release tabletNDC 42291-0507-01 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE (20 MPA.S), MICROCRYSTALLINE CELLULOSE |
| AvPAK 3 products | ||
| 750 mg extended-release capsuleNDC 50268-0671-13 | Synthetic dyes Titanium dioxide Gelatin |
Show 7 ingredientsETHYLCELLULOSES, FD&C BLUE NO. 1, FD&C RED NO. 40, GELATIN, SODIUM LAURYL SULFATE, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 1.5 g/15 mL oral solutionNDC 50268-0674-15 | Still being read | Not read yet |
| 3 g/15 mL oral solutionNDC 50268-0675-12 | Synthetic dyes Propylene glycol |
Show 9 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, PROPYLENE GLYCOL, PROPYLPARABEN, SODIUM CITRATE, SUCRALOSE, WATER |
| B. Braun Medical Inc. 1 product | ||
| 14.9 g/100 mL injectionNDC 00264-1944-20 | None of these listed |
Show 1 ingredientWATER |
| Baxter Healthcare Corporation 3 products | ||
| 7.46 g/1000 mL injectionNDC 00338-0709-48 | None of these listed |
Show 1 ingredientWATER |
| 14.9 g/1000 mL injectionNDC 00338-0705-41 | None of these listed |
Show 1 ingredientWATER |
| 29.8 g/1000 mL injectionNDC 00338-0703-41 | None of these listed |
Show 1 ingredientWATER |
| BluePoint Laboratories 3 products | ||
| 750 mg extended-release capsuleNDC 68001-0396-00 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac |
Show 11 ingredientsETHYLCELLULOSE (20 MPA.S), FD&C RED NO. 3, FD&C YELLOW NO. 6, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, MAGNESIUM STEARATE, POTASSIUM HYDROXIDE, SHELLAC, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release capsuleNDC 68001-0619-00 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Propylene glycol |
Show 11 ingredientsETHYLCELLULOSE (20 MPA.S), FD&C BLUE NO. 1, FD&C RED NO. 3, FD&C YELLOW NO. 6, GELATIN, HYDROXYPROPYL CELLULOSE (110000 WAMW), POVIDONE, PROPYLENE GLYCOL, SHELLAC, SODIUM HYDROXIDE, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 68001-0518-00 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 7 ingredientsHYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 4000, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| Bluepoint Laboratories 2 products | ||
| 750 mg tabletNDC 68001-0566-00 | None of these listed |
Show 5 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, HYDROXYPROPYL CELLULOSE (1600000 WAMW), MICROCRYSTALLINE CELLULOSE, TALC |
| 1500 mg tabletNDC 68001-0567-00 | None of these listed |
Show 5 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, HYDROXYPROPYL CELLULOSE (1600000 WAMW), MICROCRYSTALLINE CELLULOSE, TALC |
| BPI Labs LLC 3 products | ||
| 1.5 g/1.58 g oral solutionNDC 54288-0125-10 | Synthetic dyes |
Show 5 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, ORANGE, SILICON DIOXIDE, SUCRALOSE |
| 20 mEq/15 mL oral solutionNDC 54288-0160-47 | Synthetic dyes Propylene glycol |
Show 9 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, PROPYLENE GLYCOL, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| 40 mEq/15 mL oral solutionNDC 54288-0161-47 | Synthetic dyes Propylene glycol |
Show 9 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, PROPYLENE GLYCOL, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| Bryant Ranch Prepack 20 products | ||
| 600 mg extended-release capsuleNDC 72162-1076-01 | Titanium dioxide Gelatin |
Show 5 ingredientsETHYLCELLULOSE, UNSPECIFIED, GELATIN, UNSPECIFIED, MAGNESIUM STEARATE, SODIUM LAURYL SULFATE, TITANIUM DIOXIDE |
| 600 mg extended-release tabletNDC 63629-2620-01 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 8 ingredientsFERRIC OXIDE RED, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 4000, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 63629-1072-01 | None of these listed |
Show 5 ingredientsCROSPOVIDONE, DIETHYL PHTHALATE, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE |
| 750 mg extended-release tabletNDC 63629-1073-01 | None of these listed |
Show 5 ingredientsCROSPOVIDONE, DIETHYL PHTHALATE, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE |
| 750 mg extended-release tabletNDC 63629-1074-01 | None of these listed |
Show 5 ingredientsCROSPOVIDONE, DIETHYL PHTHALATE, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE |
| 750 mg extended-release tabletNDC 63629-1075-01 | None of these listed |
Show 5 ingredientsCROSPOVIDONE, DIETHYL PHTHALATE, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE |
| 750 mg extended-release tabletNDC 71335-1131-01 | Synthetic dyes Tartrazine (FD&C Yellow No. 5) Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsETHYLCELLULOSE (10 MPA.S), ETHYLCELLULOSE (100 MPA.S), FD&C YELLOW NO. 5, FD&C YELLOW NO. 6, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 71335-1900-01 | None of these listed |
Show 5 ingredientsCROSPOVIDONE, DIETHYL PHTHALATE, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE |
| 750 mg extended-release tabletNDC 71335-2447-01 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsD&C YELLOW NO. 10, ETHYLCELLULOSE, UNSPECIFIED, FD&C YELLOW NO. 6, MAGNESIUM STEARATE, PARAFFIN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 750 mg extended-release tabletNDC 71335-2503-01 | None of these listed |
Show 5 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, HYDROXYPROPYL CELLULOSE (1600000 WAMW), MICROCRYSTALLINE CELLULOSE, TALC |
| 750 mg extended-release tabletNDC 71335-2607-01 | None of these listed |
Show 5 ingredientsCROSPOVIDONE, DIETHYL PHTHALATE, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE |
| 750 mg extended-release tabletNDC 71335-2866-01 | None of these listed |
Show 5 ingredientsCROSPOVIDONE, DIETHYL PHTHALATE, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE |
| 750 mg extended-release tabletNDC 71335-2913-01 | None of these listed |
Show 5 ingredientsCROSPOVIDONE, DIETHYL PHTHALATE, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE |
| 750 mg extended-release tabletNDC 71335-2958-01 | None of these listed |
Show 5 ingredientsCROSPOVIDONE, DIETHYL PHTHALATE, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE |
| 750 mg extended-release tabletNDC 72162-1786-00 | None of these listed |
Show 5 ingredientsCROSPOVIDONE, DIETHYL PHTHALATE, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE |
| 1500 mg extended-release tabletNDC 71335-1896-01 | None of these listed |
Show 5 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, HYDROXYPROPYL CELLULOSE (1600000 WAMW), MICROCRYSTALLINE CELLULOSE, TALC |
| 1500 mg extended-release tabletNDC 71335-1109-01 | None of these listed |
Show 6 ingredientsCROSPOVIDONE (120 .MU.M), ETHYLCELLULOSE, UNSPECIFIED, HYDROXYPROPYL CELLULOSE, UNSPECIFIED, MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE, TALC |
| 1500 mg extended-release tabletNDC 71335-1747-01 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE (20 MPA.S), MICROCRYSTALLINE CELLULOSE |
| 1500 mg extended-release tabletNDC 71335-2045-01 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE |
| 1.5 g/1.77 g oral solutionNDC 72162-2310-01 | Wheat or gluten source Synthetic dyes |
Show 5 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, MALTODEXTRIN, SILICON DIOXIDE, SUCRALOSE |
| Camber Pharmaceuticals, Inc. 5 products | ||
| 750 mg extended-release tabletNDC 31722-0133-01 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE |
| 1125 mg extended-release tabletNDC 31722-0134-01 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE |
| 1500 mg extended-release tabletNDC 31722-0135-01 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE |
| 20 mEq/15 mL oral solutionNDC 31722-0494-47 | Corn-derived Synthetic dyes Propylene glycol |
Show 10 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, Glycerin, METHYLPARABEN, PROPYLENE GLYCOL, PROPYLPARABEN, STARCH, CORN, Sucralose, TRISODIUM CITRATE DIHYDRATE, WATER |
| 40 mEq/15 mL oral solutionNDC 31722-0495-47 | Corn-derived Synthetic dyes Propylene glycol |
Show 10 ingredientsANHYDROUS CITRIC ACID, FD&C RED NO. 40, Glycerin, METHYLPARABEN, PROPYLENE GLYCOL, PROPYLPARABEN, STARCH, CORN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, Water |
| Cardinal Health 107, LLC 3 products | ||
| 1500 mg extended-release tabletNDC 55154-5634-00 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE |
| 1.5 g/1.58 g oral solutionNDC 55154-8352-05 | Synthetic dyes |
Show 4 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, SILICON DIOXIDE, SUCRALOSE |
| 1.5 g/15 mL oral solutionNDC 55154-8026-05 | Synthetic dyes Propylene glycol |
Show 10 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, ORANGE, PROPYLENE GLYCOL, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| Carwin Pharmaceutical Associates, LLC 3 products | ||
| 0.75 g/0.79 g oral solutionNDC 15370-0305-04 | Synthetic dyes |
Show 4 ingredientsAnhydrous Citric Acid, FD&C Yellow No. 6, Silicon Dioxide, Sucralose |
| 1.125 g/1.185 g oral solutionNDC 15370-0306-30 | Synthetic dyes |
Show 4 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, SILICON DIOXIDE, SUCRALOSE |
| 10 mEq/15 mL oral solutionNDC 15370-0307-04 | Synthetic dyes |
Show 7 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, SODIUM BENZOATE, SODIUM CITRATE, UNSPECIFIED FORM, SUCRALOSE, WATER |
| Coupler LLC 1 product | ||
| 750 mg extended-release tabletNDC 67046-1032-03 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 7 ingredientsHYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 4000, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| Direct_Rx 4 products | ||
| 750 mg extended-release tabletNDC 72189-0648-04 | None of these listed |
Show 5 ingredientsCELLULOSE, MICROCRYSTALLINE, CROSCARMELLOSE SODIUM, ETHYLCELLULOSES, HYDROXYPROPYL CELLULOSE (1600000 WAMW), TALC |
| 750 mg extended-release tabletNDC 72189-0027-04 | Synthetic dyes Tartrazine (FD&C Yellow No. 5) Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsETHYLCELLULOSE (10 MPA.S), ETHYLCELLULOSE (100 MPA.S), FD&C YELLOW NO. 5, FD&C YELLOW NO. 6, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 1500 mg extended-release tabletNDC 72189-0629-30 | Still being read | Not read yet |
| 1500 mg extended-release tabletNDC 72189-0462-30 | None of these listed |
Show 6 ingredientsCROSPOVIDONE (15 MPA.S AT 5%), ETHYLCELLULOSE, UNSPECIFIED, HYDROXYPROPYL CELLULOSE, UNSPECIFIED, MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE, TALC |
| Dr. Reddys Laboratories, Inc. 2 products | ||
| 20 mEq/15 mL oral solutionNDC 43598-0891-10 | Still being read | Not read yet |
| 40 mEq/30 mL oral solutionNDC 43598-0160-01 | Still being read | Not read yet |
| Endo USA, Inc. 2 products | ||
| 1.5 g/1.58 g oral solutionNDC 00603-1554-04 | Synthetic dyes |
Show 4 ingredientsAnhydrous Citric Acid, FD&C Yellow No. 6, Silicon Dioxide, Sucralose |
| 20 mEq/15 mL oral solutionNDC 00603-1542-58 | Synthetic dyes |
Show 7 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, Glycerin, Sodium Benzoate, SODIUM CITRATE, UNSPECIFIED FORM, Sucralose, Water |
| Epic Pharma, LLC 3 products | ||
| 600 mg extended-release tabletNDC 42806-0422-01 | Soy Titanium dioxide Polyethylene glycol or polysorbate |
Show 8 ingredientsHYDROGENATED COTTONSEED OIL, HYDROXYPROPYL CELLULOSE, UNSPECIFIED, LECITHIN, SOYBEAN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 42806-0423-01 | Soy Titanium dioxide Polyethylene glycol or polysorbate |
Show 8 ingredientsHYDROGENATED COTTONSEED OIL, HYDROXYPROPYL CELLULOSE, UNSPECIFIED, LECITHIN, SOYBEAN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 1.5 g/1.77 g oral solutionNDC 42806-0094-01 | Wheat or gluten source Synthetic dyes |
Show 5 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, MALTODEXTRIN, SILICON DIOXIDE, SUCRALOSE |
| Fresenius Kabi USA, LLC 7 products | ||
| 2 mEq/mL injectionNDC 63323-0965-05 | None of these listed |
Show 3 ingredientsHYDROCHLORIC ACID, POTASSIUM HYDROXIDE, WATER |
| 2 mEq/mL injectionNDC 63323-0967-30 | None of these listed |
Show 5 ingredientsHYDROCHLORIC ACID, METHYLPARABEN, POTASSIUM HYDROXIDE, PROPYLPARABEN, WATER |
| 10 mEq/50 mL injectionNDC 65219-0004-01 | None of these listed |
Show 1 ingredientWATER |
| 10 mEq/100 mL injectionNDC 65219-0012-01 | None of these listed |
Show 1 ingredientWATER |
| 20 mEq/50 mL injectionNDC 65219-0008-51 | None of these listed |
Show 1 ingredientWATER |
| 20 mEq/100 mL injectionNDC 65219-0006-01 | None of these listed |
Show 1 ingredientWATER |
| 40 mEq/100 mL injectionNDC 65219-0010-01 | None of these listed |
Show 1 ingredientWATER |
| Genus Lifesciences 1 product | ||
| 20 mEq/15 mL oral solutionNDC 64950-0320-47 | Synthetic dyes |
Show 7 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW No. 6, GLYCERIN, SODIUM BENZOATE, SODIUM CITRATE, UNSPECIFIED FORM, SUCRALOSE, WATER |
| Genus Lifesciences Inc. 1 product | ||
| 1.5 g/1.58 g oral solutionNDC 64950-0321-01 | Synthetic dyes |
Show 4 ingredientsAnhydrous Citric Acid, FD&C Yellow No. 6, Silicon Dioxide, Sucralose |
| Glenmark Pharmaceuticals Inc., USA 1 product | ||
| 750 mg extended-release capsuleNDC 68462-0357-01 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac |
Show 11 ingredientsETHYLCELLULOSE (20 MPA.S), FD&C RED NO. 3, FD&C YELLOW NO. 6, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, MAGNESIUM STEARATE, POTASSIUM HYDROXIDE, SHELLAC, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE |
| Granules India Ltd 4 products | ||
| 600 mg extended-release capsuleNDC 62207-0914-43 | Titanium dioxide Gelatin Carmine or shellac Propylene glycol |
Show 8 ingredientsETHYLCELLULOSE (20 MPA.S), FERROSOFERRIC OXIDE, GELATIN, HYDROXYPROPYL CELLULOSE (110000 WAMW), POTASSIUM HYDROXIDE, PROPYLENE GLYCOL, SHELLAC, TITANIUM DIOXIDE |
| 750 mg extended-release capsuleNDC 62207-0915-43 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Propylene glycol |
Show 11 ingredientsETHYLCELLULOSE (20 MPA.S), FD&C BLUE NO. 1, FD&C RED NO. 3, FD&C YELLOW NO. 6, GELATIN, HYDROXYPROPYL CELLULOSE (110000 WAMW), POVIDONE, PROPYLENE GLYCOL, SHELLAC, SODIUM HYDROXIDE, TITANIUM DIOXIDE |
| 750 mg tabletNDC 62207-0726-43 | None of these listed |
Show 5 ingredientsCELLULOSE, MICROCRYSTALLINE, CROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, HYDROXYPROPYL CELLULOSE, TALC |
| 1500 mg tabletNDC 62207-0727-08 | None of these listed |
Show 5 ingredientsCELLULOSE, MICROCRYSTALLINE, CROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, HYDROXYPROPYL CELLULOSE, TALC |
| Granules Pharmaceuticals Inc 2 products | ||
| 600 mg extended-release capsuleNDC 70010-0147-01 | Titanium dioxide Gelatin Carmine or shellac Propylene glycol |
Show 8 ingredientsETHYLCELLULOSES, FERROSOFERRIC OXIDE, GELATIN, HYDROXYPROPYL CELLULOSE, POTASSIUM HYDROXIDE, PROPYLENE GLYCOL, SHELLAC, TITANIUM DIOXIDE |
| 750 mg extended-release capsuleNDC 70010-0148-01 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Propylene glycol |
Show 11 ingredientsETHYLCELLULOSE (20 MPA.S), FD&C BLUE NO. 1, FD&C RED NO. 3, FD&C YELLOW NO. 6, GELATIN, HYDROXYPROPYL CELLULOSE (110000 WAMW), POVIDONE, PROPYLENE GLYCOL, SHELLAC, SODIUM HYDROXIDE, TITANIUM DIOXIDE |
| Granules Pharmaceuticals Inc. 7 products | ||
| 600 mg extended-release tabletNDC 70010-0021-01 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 12 ingredientsFD&C BLUE NO. 1, FD&C BLUE NO. 2, FERRIC OXIDE YELLOW, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, POVIDONE, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 70010-0136-01 | None of these listed |
Show 5 ingredientsCELLULOSE, MICROCRYSTALLINE, CROSCARMELLOSE SODIUM, ETHYLCELLULOSES, HYDROXYPROPYL CELLULOSE, TALC |
| 750 mg extended-release tabletNDC 70010-0022-01 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsD&C YELLOW NO. 10, FD&C YELLOW NO. 6, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, POVIDONE, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 1500 mg extended-release tabletNDC 70010-0135-01 | None of these listed |
Show 5 ingredientsCELLULOSE, MICROCRYSTALLINE, CROSCARMELLOSE SODIUM, ETHYLCELLULOSES, HYDROXYPROPYL CELLULOSE, TALC |
| 1.5 g/1.58 g oral solutionNDC 70010-0071-41 | Synthetic dyes |
Show 4 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, SILICON DIOXIDE, SUCRALOSE |
| 20 mEq/15 mL oral solutionNDC 70010-0072-44 | Synthetic dyes Propylene glycol |
Show 9 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, PROPYLENE GLYCOL, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| 40 mEq/15 mL oral solutionNDC 70010-0073-44 | Still being read | Not read yet |
| Guardian Drug Company 3 products | ||
| 1.5 g/1.57 g oral solutionNDC 53041-0420-49 | Synthetic dyes |
Show 4 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, SILICON DIOXIDE, SUCRALOSE |
| 20 mEq/15 mL oral solutionNDC 53041-0681-06 | Still being read | Not read yet |
| 40 mEq/15 mL oral solutionNDC 53041-0680-06 | Still being read | Not read yet |
| Henry Schein, Inc. 2 products | ||
| 2 mEq/mL injectionNDC 00404-9936-10 | None of these listed |
Show 1 ingredientPOTASSIUM HYDROXIDE |
| 149 mg/mL injectionNDC 00404-9937-10 | None of these listed |
Show 2 ingredientsHYDROCHLORIC ACID, WATER |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 1 product | ||
| 1.5 g/1.58 g oral solutionNDC 23155-0856-76 | Synthetic dyes |
Show 4 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, SILICON DIOXIDE, SUCRALOSE |
| HF Acquisition Co LLC, DBA HealthFirst 2 products | ||
| 149 mg/mL injectionNDC 51662-1421-01 | None of these listed |
Show 2 ingredientsHYDROCHLORIC ACID, WATER |
| 149 mg/mL injectionNDC 51662-1387-01 | None of these listed |
Show 2 ingredientsHYDROCHLORIC ACID, WATER |
| Hospira, Inc. 3 products | ||
| 149 mg/mL injectionNDC 00409-6635-01 | None of these listed |
Show 2 ingredientsHYDROCHLORIC ACID, WATER |
| 149 mg/mL injectionNDC 00409-6651-06 | None of these listed |
Show 2 ingredientsHYDROCHLORIC ACID, WATER |
| 149 mg/mL injectionNDC 00409-6653-05 | Still being read | Not read yet |
| ICU Medical Inc. 3 products | ||
| 10 mEq/100 mL injectionNDC 00990-7074-26 | None of these listed |
Show 1 ingredientWATER |
| 200 mEq/1000 mL injectionNDC 00990-7075-14 | None of these listed |
Show 1 ingredientWATER |
| 400 mEq/1000 mL injectionNDC 00990-7077-14 | None of these listed |
Show 1 ingredientWATER |
| IPG Pharmaceuticals, Inc. 1 product | ||
| 3 g/3.16 g oral solutionNDC 71085-0083-30 | Synthetic dyes |
Show 4 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, SILICON DIOXIDE, SUCRALOSE |
| Kesin Pharma Corporation 3 products | ||
| 1.5 g/1.58 g oral solutionNDC 81033-0413-01 | Synthetic dyes |
Show 4 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, SILICON DIOXIDE, SUCRALOSE |
| 1.5 g/15 mL oral solutionNDC 81033-0220-51 | Synthetic dyes Propylene glycol |
Show 10 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, ORANGE, PROPYLENE GLYCOL, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| 3 g/30 mL oral solutionNDC 81033-0240-50 | Synthetic dyes Propylene glycol |
Show 10 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, ORANGE, PROPYLENE GLYCOL, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| Lupin Pharmaceuticals, Inc. 1 product | ||
| 10 mEq extended-release capsuleNDC 68180-0799-01 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Propylene glycol |
Show 12 ingredientsETHYLCELLULOSE (10 MPA.S), ETHYLCELLULOSE (45 MPA.S), FD&C BLUE NO. 1, FD&C RED NO. 40, GELATIN, POTASSIUM HYDROXIDE, PROPYLENE GLYCOL, SHELLAC, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| Lupin Pharmaceuticals,Inc. 5 products | ||
| 10 mEq extended-release tabletNDC 43386-0915-01 | Alcohol (ethanol) |
Show 6 ingredientsALCOHOL, CELLULOSE, MICROCRYSTALLINE, CROSCARMELLOSE SODIUM, ETHYLCELLULOSE (45 MPA.S), ISOPROPYL ALCOHOL, TRIETHYL CITRATE |
| 20 mEq extended-release tabletNDC 43386-0917-01 | Alcohol (ethanol) |
Show 6 ingredientsALCOHOL, CELLULOSE, MICROCRYSTALLINE, CROSCARMELLOSE SODIUM, ETHYLCELLULOSE (45 MPA.S), ISOPROPYL ALCOHOL, TRIETHYL CITRATE |
| 1.5 g/1.54 g oral solutionNDC 43386-0194-30 | Synthetic dyes |
Show 5 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, ORANGE, SILICON DIOXIDE, SUCRALOSE |
| 20 mEq/15 mL oral solutionNDC 43386-0168-01 | Synthetic dyes Propylene glycol |
Show 10 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, ORANGE, PROPYLENE GLYCOL, PROPYLPARABEN, SODIUM CITRATE, SUCRALOSE, WATER |
| 40 mEq/15 mL oral solutionNDC 43386-0169-01 | Synthetic dyes Propylene glycol |
Show 10 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, ORANGE, PROPYLENE GLYCOL, PROPYLPARABEN, SODIUM CITRATE, SUCRALOSE, WATER |
| Macleods Pharmaceuticals Limited 4 products | ||
| 600 mg extended-release tabletNDC 33342-0417-11 | Still being read | Not read yet |
| 750 mg extended-release tabletNDC 33342-0418-11 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 7 ingredientsHYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, Polyethylene glycol 6000, POLYVINYL ALCOHOL, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 20 mEq/15 mL oral solutionNDC 33342-0511-73 | Synthetic dyes Propylene glycol |
Show 10 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, PROPYLENE GLYCOL, SODIUM BENZOATE, SODIUM CHLORIDE, SODIUM SULFATE, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| 40 mEq/15 mL oral solutionNDC 33342-0512-73 | Still being read | Not read yet |
| Major Pharmaceuticals 7 products | ||
| 750 mg extended-release capsuleNDC 00904-7543-61 | Synthetic dyes Titanium dioxide Gelatin |
Show 7 ingredientsETHYLCELLULOSE, UNSPECIFIED, FD&C BLUE NO. 1, FD&C RED NO. 40, GELATIN, UNSPECIFIED, SODIUM LAURYL SULFATE, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 20 mEq extended-release tabletNDC 00904-7548-61 | None of these listed |
Show 5 ingredientsCROSPOVIDONE, UNSPECIFIED, DIETHYL PHTHALATE, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE |
| 750 mg extended-release tabletNDC 00904-7547-61 | None of these listed |
Show 5 ingredientsCROSPOVIDONE, UNSPECIFIED, DIETHYL PHTHALATE, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE |
| 750 mg extended-release tabletNDC 00904-7216-61 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 7 ingredientsHYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 4000, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 1500 mg extended-release tabletNDC 00904-7293-61 | None of these listed |
Show 4 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE (20 MPA.S), MICROCRYSTALLINE CELLULOSE, TRIETHYL CITRATE |
| 20 mEq/15 mL oral solutionNDC 00904-7461-46 | Synthetic dyes Propylene glycol |
Show 9 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, PROPYLENE GLYCOL, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| 40 mEq/30 mL oral solutionNDC 00904-7462-43 | Synthetic dyes Propylene glycol |
Show 9 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, PROPYLENE GLYCOL, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| Marlex Pharmaceuticals, Inc. 1 product | ||
| 1.5 g/1.58 g oral solutionNDC 10135-0807-13 | Synthetic dyes |
Show 5 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, ORANGE, SILICON DIOXIDE, SUCRALOSE |
| Marlex Pharmaceuticals Inc 2 products | ||
| 1.5 g/1.58 g oral solutionNDC 10135-0819-08 | Synthetic dyes |
Show 9 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, ORANGE, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| 3 g/4.75 g oral solutionNDC 10135-0820-08 | Synthetic dyes |
Show 9 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, ORANGE, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| Mylan Pharmaceuticals Inc. 2 products | ||
| 8 mEq extended-release tabletNDC 00378-4560-05 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 9 ingredientsETHYLCELLULOSE, UNSPECIFIED, FERRIC OXIDE RED, FERRIC OXIDE YELLOW, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, STEARIC ACID, TALC, TITANIUM DIOXIDE |
| 10 mEq extended-release tabletNDC 00378-4561-05 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 9 ingredientsETHYLCELLULOSE, UNSPECIFIED, FERRIC OXIDE RED, FERRIC OXIDE YELLOW, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, STEARIC ACID, TALC, TITANIUM DIOXIDE |
| NCS HealthCare of KY, LLC dba Vangard Labs 5 products | ||
| 750 mg extended-release capsuleNDC 00615-8442-05 | Synthetic dyes Titanium dioxide Gelatin Propylene glycol |
Show 10 ingredientsETHYLCELLULOSE (20 MPA.S), FD&C BLUE NO. 1, FD&C RED NO. 3, FD&C YELLOW NO. 6, GELATIN, HYDROXYPROPYL CELLULOSE (110000 WAMW), POVIDONE, PROPYLENE GLYCOL, SODIUM HYDROXIDE, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 00615-8399-05 | None of these listed |
Show 5 ingredientsCELLULOSE, MICROCRYSTALLINE, CROSCARMELLOSE SODIUM, ETHYLCELLULOSES, HYDROXYPROPYL CELLULOSE (1600000 WAMW), TALC |
| 750 mg extended-release tabletNDC 00615-8570-05 | Soy Titanium dioxide Polyethylene glycol or polysorbate |
Show 8 ingredientsHYDROGENATED COTTONSEED OIL, HYDROXYPROPYL CELLULOSE, UNSPECIFIED, LECITHIN, SOYBEAN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 1500 mg extended-release tabletNDC 00615-8400-05 | None of these listed |
Show 5 ingredientsCELLULOSE, MICROCRYSTALLINE, CROSCARMELLOSE SODIUM, ETHYLCELLULOSES, HYDROXYPROPYL CELLULOSE (1600000 WAMW), TALC |
| 1500 mg extended-release tabletNDC 00615-8580-05 | Still being read | Not read yet |
| Nexus Pharamaceuticals Inc. 3 products | ||
| 7.45 mg/mL injectionNDC 14789-0109-10 | No inactive-ingredient list on the label | No list we could read |
| 14.9 mg/mL injectionNDC 14789-0108-05 | No inactive-ingredient list on the label | No list we could read |
| 29.8 mg/mL injectionNDC 14789-0107-05 | No inactive-ingredient list on the label | No list we could read |
| Northstar Rx LLC 4 products | ||
| 750 mg extended-release capsuleNDC 16714-0824-01 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac |
Show 11 ingredientsETHYLCELLULOSE (20 MPA.S), FD&C RED NO. 3, FD&C YELLOW NO. 6, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, MAGNESIUM STEARATE, POTASSIUM HYDROXIDE, SHELLAC, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 72603-0337-01 | None of these listed |
Show 3 ingredientscroscarmellose sodium, ethylcellulose, unspecified, microcrystalline cellulose |
| 1500 mg extended-release tabletNDC 72603-0338-01 | None of these listed |
Show 3 ingredientscroscarmellose sodium, ethylcellulose, unspecified, microcrystalline cellulose |
| 1.5 g/1.58 g oral solutionNDC 72603-0407-01 | Synthetic dyes |
Show 4 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, SILICON DIOXIDE, SUCRALOSE |
| Northwind Health Company, LLC 6 products | ||
| 750 mg extended-release tabletNDC 82868-0027-90 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE (20 MPA.S), MICROCRYSTALLINE CELLULOSE |
| 750 mg extended-release tabletNDC 82868-0111-90 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsD&C YELLOW NO. 10 ALUMINUM LAKE, ETHYLCELLULOSES, FD&C YELLOW NO. 6, MAGNESIUM STEARATE, PARAFFIN, POLYETHYLENE GLYCOL 4000, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 750 mg extended-release tabletNDC 51655-0706-52 | Synthetic dyes Tartrazine (FD&C Yellow No. 5) Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsETHYLCELLULOSE (10 MPA.S), ETHYLCELLULOSE (100 MPA.S), FD&C YELLOW NO. 5, FD&C YELLOW NO. 6, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 51655-0226-26 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 9 ingredientsD&C YELLOW NO. 10, FD&C YELLOW NO. 6, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 51655-0463-84 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 7 ingredientsHYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 4000, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 1500 mg extended-release tabletNDC 51655-0568-25 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE (20 MPA.S), MICROCRYSTALLINE CELLULOSE |
| Novel Laboratories, Inc. 1 product | ||
| 1.5 g/1.54 g oral solutionNDC 40032-0194-30 | Synthetic dyes |
Show 4 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, SILICON DIOXIDE, SUCRALOSE |
| PAI Holdings, LLC dba PAI Pharma 4 products | ||
| 20 mEq/15 mL oral solutionNDC 00121-0948-16 | Synthetic dyes |
Show 7 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, SODIUM BENZOATE, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| 20 mEq/15 mL oral solutionNDC 00121-4948-00 | Synthetic dyes |
Show 7 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, SODIUM BENZOATE, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| 20 mEq/30 mL oral solutionNDC 00121-1896-00 | Synthetic dyes |
Show 7 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, SODIUM BENZOATE, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| 40 mEq/15 mL oral solutionNDC 00121-2847-00 | Synthetic dyes |
Show 7 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, SODIUM BENZOATE, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| PD-Rx Pharmaceuticals, Inc. 5 products | ||
| 600 mg extended-release capsuleNDC 72789-0056-01 | Titanium dioxide Gelatin |
Show 5 ingredientsETHYLCELLULOSE, UNSPECIFIED, GELATIN, UNSPECIFIED, MAGNESIUM STEARATE, SODIUM LAURYL SULFATE, TITANIUM DIOXIDE |
| 750 mg extended-release capsuleNDC 72789-0057-01 | Synthetic dyes Titanium dioxide Gelatin |
Show 8 ingredientsETHYLCELLULOSE, UNSPECIFIED, FD&C BLUE NO. 1, FD&C RED NO. 3, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, MAGNESIUM STEARATE, SODIUM LAURYL SULFATE, TITANIUM DIOXIDE |
| 20 mEq extended-release tabletNDC 72789-0365-01 | None of these listed |
Show 5 ingredientsCROSPOVIDONE, UNSPECIFIED, DIETHYL PHTHALATE, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE |
| 750 mg extended-release tabletNDC 72789-0503-95 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsMAGNESIUM STEARATE, PARAFFIN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ACETATE, POLYVINYL ALCOHOL, UNSPECIFIED, POVIDONE, UNSPECIFIED, SILICON DIOXIDE, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 1500 mg extended-release tabletNDC 72789-0504-82 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsMAGNESIUM STEARATE, PARAFFIN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ACETATE, POLYVINYL ALCOHOL, UNSPECIFIED, POVIDONE, UNSPECIFIED, SILICON DIOXIDE, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| Preferred Pharmaceuticals Inc. 2 products | ||
| 750 mg extended-release tabletNDC 68788-8262-03 | Still being read | Not read yet |
| 1500 mg extended-release tabletNDC 68788-8196-03 | None of these listed |
Show 5 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, HYDROXYPROPYL CELLULOSE (1600000 WAMW), MICROCRYSTALLINE CELLULOSE, TALC |
| Proficient Rx LP 5 products | ||
| 20 mEq extended-release tabletNDC 82804-0075-03 | Still being read | Not read yet |
| 750 mg extended-release tabletNDC 82804-0109-30 | None of these listed |
Show 5 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, HYDROXYPROPYL CELLULOSE (1600000 WAMW), MICROCRYSTALLINE CELLULOSE, TALC |
| 750 mg extended-release tabletNDC 82804-0187-30 | Soy Titanium dioxide Polyethylene glycol or polysorbate |
Show 8 ingredientsHYDROGENATED COTTONSEED OIL, HYDROXYPROPYL CELLULOSE, UNSPECIFIED, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, SOYBEAN LECITHIN, TALC, TITANIUM DIOXIDE |
| 1500 mg extended-release tabletNDC 71205-0824-03 | None of these listed |
Show 5 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, HYDROXYPROPYL CELLULOSE (1600000 WAMW), MICROCRYSTALLINE CELLULOSE, TALC |
| 1500 mg extended-release tabletNDC 82804-0057-30 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 9 ingredientsETHYLCELLULOSE, UNSPECIFIED, Magnesium Stearate, PARAFFIN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, Silicon Dioxide, Talc, Titanium Dioxide, Triethyl Citrate |
| Redpharm Drug 3 products | ||
| 1500 mg extended-release tabletNDC 67296-2131-02 | None of these listed |
Show 6 ingredientsCROSPOVIDONE (120 .MU.M), ETHYLCELLULOSE, UNSPECIFIED, HYDROXYPROPYL CELLULOSE, UNSPECIFIED, MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE, TALC |
| 1500 mg extended-release tabletNDC 67296-2160-01 | None of these listed |
Show 5 ingredientsCELLULOSE, MICROCRYSTALLINE, CROSCARMELLOSE SODIUM, ETHYLCELLULOSES, HYDROXYPROPYL CELLULOSE, TALC |
| 1500 mg extended-release tabletNDC 67296-2243-06 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE (20 MPA.S), MICROCRYSTALLINE CELLULOSE |
| Remedyrepack Inc. 6 products | ||
| 750 mg extended-release capsuleNDC 70518-4050-00 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Propylene glycol |
Show 11 ingredientsETHYLCELLULOSE (20 MPA.S), FD&C BLUE NO. 1, FD&C RED NO. 3, FD&C YELLOW NO. 6, GELATIN, HYDROXYPROPYL CELLULOSE (110000 WAMW), POVIDONE, PROPYLENE GLYCOL, SHELLAC, SODIUM HYDROXIDE, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 70518-3024-01 | None of these listed |
Show 5 ingredientsCROSPOVIDONE, UNSPECIFIED, DIETHYL PHTHALATE, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE |
| 750 mg extended-release tabletNDC 70518-4095-02 | None of these listed |
Show 5 ingredientsCELLULOSE, MICROCRYSTALLINE, CROSCARMELLOSE SODIUM, ETHYLCELLULOSES, HYDROXYPROPYL CELLULOSE, TALC |
| 750 mg extended-release tabletNDC 70518-4520-00 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsD&C YELLOW NO. 10, FD&C YELLOW NO. 6, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, POVIDONE, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 70518-2964-00 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 7 ingredientsHYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 4000, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 1500 mg extended-release tabletNDC 70518-4383-00 | None of these listed |
Show 5 ingredientsCELLULOSE, MICROCRYSTALLINE, CROSCARMELLOSE SODIUM, ETHYLCELLULOSES, HYDROXYPROPYL CELLULOSE, TALC |
| Rising Pharma Holdings, Inc. 2 products | ||
| 600 mg extended-release tabletNDC 16571-0842-01 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsETHYLCELLULOSE, UNSPECIFIED, FD&C BLUE NO. 1, FD&C BLUE NO. 2, ISOPROPYL ALCOHOL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, SILICON DIOXIDE, STEARIC ACID, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 16571-0843-01 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsD&C YELLOW NO. 10, ETHYLCELLULOSE, UNSPECIFIED, FD&C YELLOW NO. 6, ISOPROPYL ALCOHOL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, SILICON DIOXIDE, STEARIC ACID, TALC, TITANIUM DIOXIDE |
| Saptalis Pharmaceuticals, LLC 2 products | ||
| 1.5 g/15 mL oral solutionNDC 71656-0021-01 | Synthetic dyes Propylene glycol |
Show 10 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, ORANGE, PROPYLENE GLYCOL, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| 3 g/15 mL oral solutionNDC 71656-0022-01 | Synthetic dyes Propylene glycol |
Show 10 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, ORANGE, PROPYLENE GLYCOL, PROPYLPARABEN, SUCRALOSE, TRISODIUM CITRATE DIHYDRATE, WATER |
| Slate Run Pharmaceuticals, LLC 4 products | ||
| 600 mg extended-release tabletNDC 70436-0001-01 | Soy Titanium dioxide Polyethylene glycol or polysorbate |
Show 8 ingredientsHYDROGENATED COTTONSEED OIL, HYDROXYPROPYL CELLULOSE, UNSPECIFIED, LECITHIN, SOYBEAN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 70436-0002-01 | Soy Titanium dioxide Polyethylene glycol or polysorbate |
Show 8 ingredientsHYDROGENATED COTTONSEED OIL, HYDROXYPROPYL CELLULOSE, UNSPECIFIED, LECITHIN, SOYBEAN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 70436-0152-01 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 14 ingredientsFERRIC OXIDE YELLOW, FERROSOFERRIC OXIDE, GLYCERYL MONO- AND DICAPRYLOCAPRATE, HYDROGENATED COTTONSEED OIL, MICROCRYSTALLINE CELLULOSE, POLYVINYL ACETATE, POLYVINYL ALCOHOL, POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER (3:1; 45000 MW), POVIDONE K30, SILICON DIOXIDE, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 1500 mg extended-release tabletNDC 70436-0153-01 | Still being read | Not read yet |
| Solco Healthcare LLC 5 products | ||
| 600 mg extended-release capsuleNDC 43547-0552-10 | Titanium dioxide Gelatin Carmine or shellac Propylene glycol |
Show 8 ingredientsETHYLCELLULOSE, UNSPECIFIED, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, POTASSIUM HYDROXIDE, PROPYLENE GLYCOL, SHELLAC, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release capsuleNDC 43547-0553-10 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Propylene glycol |
Show 10 ingredientsETHYLCELLULOSE, UNSPECIFIED, FD&C BLUE NO. 1, FD&C RED NO. 3, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, POTASSIUM HYDROXIDE, PROPYLENE GLYCOL, SHELLAC, TALC, TITANIUM DIOXIDE |
| 750 mg tabletNDC 43547-0549-10 | None of these listed |
Show 5 ingredientsCOPOVIDONE K25-31, CROSCARMELLOSE SODIUM, ETHYLCELLULOSE (10 MPA.S), MICROCRYSTALLINE CELLULOSE, SODIUM STEARYL FUMARATE |
| 1125 mg tabletNDC 43547-0551-10 | None of these listed |
Show 5 ingredientsCOPOVIDONE K25-31, CROSCARMELLOSE SODIUM, ETHYLCELLULOSE (10 MPA.S), MICROCRYSTALLINE CELLULOSE, SODIUM STEARYL FUMARATE |
| 1500 mg tabletNDC 43547-0550-10 | Still being read | Not read yet |
| Somerset Therapeutics, LLC 1 product | ||
| 1.5 g/1.58 g oral solutionNDC 70069-0823-01 | Synthetic dyes |
Show 4 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, SILICON DIOXIDE, SUCRALOSE |
| St. Mary's Medical Park Pharmacy 1 product | ||
| 750 mg extended-release tabletNDC 60760-0423-90 | Soy Titanium dioxide Polyethylene glycol or polysorbate |
Show 8 ingredientsHYDROGENATED COTTONSEED OIL, HYDROXYPROPYL CELLULOSE, UNSPECIFIED, LECITHIN, SOYBEAN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| Strides Pharma Science Limited 3 products | ||
| 600 mg extended-release tabletNDC 64380-0860-06 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsETHYLCELLULOSE (10 MPA.S), ETHYLCELLULOSE (100 MPA.S), FD&C BLUE NO. 1, FD&C BLUE NO. 2, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 64380-0861-06 | Synthetic dyes Tartrazine (FD&C Yellow No. 5) Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsETHYLCELLULOSE (10 MPA.S), ETHYLCELLULOSE (100 MPA.S), FD&C YELLOW NO. 5, FD&C YELLOW NO. 6, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 1.5 g/1.58 g oral solutionNDC 64380-0875-68 | Synthetic dyes |
Show 4 ingredientsANHYDROUS CITRIC ACID, FD&C YELLOW NO. 6, SILICON DIOXIDE, SUCRALOSE |
| Sun Pharmaceutical Industries, Inc. 4 products | ||
| 600 mg extended-release capsuleNDC 63304-0078-01 | Titanium dioxide Gelatin |
Show 5 ingredientsETHYLCELLULOSE, UNSPECIFIED, GELATIN, UNSPECIFIED, MAGNESIUM STEARATE, SODIUM LAURYL SULFATE, TITANIUM DIOXIDE |
| 750 mg extended-release capsuleNDC 63304-0090-01 | Synthetic dyes Titanium dioxide Gelatin |
Show 8 ingredientsETHYLCELLULOSE, UNSPECIFIED, FD&C BLUE NO. 1, FD&C RED NO. 3, FERROSOFERRIC OXIDE, GELATIN, UNSPECIFIED, MAGNESIUM STEARATE, SODIUM LAURYL SULFATE, TITANIUM DIOXIDE |
| 20 mEq extended-release tabletNDC 63304-0987-01 | None of these listed |
Show 5 ingredientsCROSPOVIDONE, UNSPECIFIED, DIETHYL PHTHALATE, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE |
| 750 mg extended-release tabletNDC 63304-0076-01 | None of these listed |
Show 5 ingredientsCROSPOVIDONE, UNSPECIFIED, DIETHYL PHTHALATE, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE |
| Tris Pharma Inc 2 products | ||
| 20 mEq/15 mL oral solutionNDC 27808-0168-01 | Synthetic dyes Propylene glycol |
Show 10 ingredientsANHYDROUS CITRIC ACID, CALCIUM, FD&C YELLOW NO. 6, GLYCERIN, METHYLPARABEN, PROPYLENE GLYCOL, PROPYLPARABEN, SODIUM CITRATE, UNSPECIFIED FORM, SUCRALOSE, WATER |
| 40 mEq/15 mL oral solutionNDC 27808-0169-01 | Still being read | Not read yet |
| Upsher-Smith Laboratories, LLC 14 products | ||
| 600 mg extended-release tabletNDC 24979-0229-00 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 9 ingredientsETHYLCELLULOSES, MAGNESIUM STEARATE, PARAFFIN, POLYETHYLENE GLYCOL 3350, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 600 mg extended-release tabletNDC 00245-0835-11 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 9 ingredientsETHYLCELLULOSE, MAGNESIUM STEARATE, PARAFFIN, POLYETHYLENE GLYCOL 3350, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 600 mg extended-release tabletNDC 00245-5315-01 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 9 ingredientsFD&C BLUE NO. 1, FD&C BLUE NO. 2, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 600 mg extended-release tabletNDC 00832-5322-10 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 9 ingredientsFD&C BLUE NO. 1, FD&C BLUE NO. 2, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 24979-0231-01 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsD&C Yellow No. 10, ETHYLCELLULOSE, UNSPECIFIED, FD&C Yellow No. 6, Magnesium Stearate, PARAFFIN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, Silicon Dioxide, Talc, Titanium Dioxide, Triethyl Citrate |
| 750 mg extended-release tabletNDC 24979-0230-00 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsD&C YELLOW NO. 10 ALUMINUM LAKE, ETHYLCELLULOSES, FD&C YELLOW NO. 6, MAGNESIUM STEARATE, PARAFFIN, POLYETHYLENE GLYCOL 4000, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 750 mg extended-release tabletNDC 00245-5317-01 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE |
| 750 mg extended-release tabletNDC 00245-0836-11 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 11 ingredientsD&C YELLOW NO. 10 ALUMINUM LAKE, ETHYLCELLULOSE, FD&C YELLOW NO. 6, MAGNESIUM STEARATE, PARAFFIN, POLYETHYLENE GLYCOL 4000, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 750 mg extended-release tabletNDC 00245-5316-01 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 9 ingredientsD&C YELLOW NO. 10, FD&C YELLOW NO. 6, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 00832-5323-10 | Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 9 ingredientsD&C YELLOW NO. 10, FD&C YELLOW NO. 6, HYDROGENATED COTTONSEED OIL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 1125 mg extended-release tabletNDC 00245-5318-01 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE |
| 1500 mg extended-release tabletNDC 24979-0232-01 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 9 ingredientsETHYLCELLULOSE, UNSPECIFIED, Magnesium Stearate, PARAFFIN, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYVINYL ALCOHOL, UNSPECIFIED, Silicon Dioxide, Talc, Titanium Dioxide, Triethyl Citrate |
| 1500 mg extended-release tabletNDC 00245-5319-01 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE |
| 1.5 g oral solutionNDC 00245-0360-01 | Wheat or gluten source Corn-derived Synthetic dyes |
Show 8 ingredientsCITRIC ACID MONOHYDRATE, FD&C YELLOW NO. 6, MALIC ACID, MALTODEXTRIN, MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE), NEOTAME, SILICON DIOXIDE, TOCOPHEROL |
| Upsher-SmithLaboratories, LLC 2 products | ||
| 750 mg extended-release tabletNDC 00832-5324-10 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE (20 MPA.S), MICROCRYSTALLINE CELLULOSE |
| 1500 mg extended-release tabletNDC 00832-5325-10 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE (20 MPA.S), MICROCRYSTALLINE CELLULOSE |
| XLCare Pharmaceuticals, Inc. 3 products | ||
| 750 mg extended-release tabletNDC 72865-0194-01 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE |
| 1125 mg extended-release tabletNDC 72865-0195-01 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE |
| 1500 mg extended-release tabletNDC 72865-0196-01 | None of these listed |
Show 3 ingredientsCROSCARMELLOSE SODIUM, ETHYLCELLULOSE, UNSPECIFIED, MICROCRYSTALLINE CELLULOSE |
| Zydus Pharmaceuticals (USA) Inc. 4 products | ||
| 600 mg extended-release capsuleNDC 68382-0853-01 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Propylene glycol Polyethylene glycol or polysorbate |
Show 15 ingredientsD&C YELLOW NO. 10, ETHYLCELLULOSE (45 MPA.S), FD&C BLUE NO. 1, FD&C BLUE NO. 2, FD&C RED NO. 40, FERROSOFERRIC OXIDE, GELATIN, HYPROMELLOSE 2910 (5 MPA.S), POLYETHYLENE GLYCOL 8000, PROPYLENE GLYCOL, SHELLAC, SILICON DIOXIDE, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release capsuleNDC 68382-0854-01 | Synthetic dyes Titanium dioxide Gelatin Carmine or shellac Propylene glycol Polyethylene glycol or polysorbate |
Show 15 ingredientsD&C YELLOW NO. 10, ETHYLCELLULOSE (45 MPA.S), FD&C BLUE NO. 1, FD&C BLUE NO. 2, FD&C RED NO. 40, FERROSOFERRIC OXIDE, GELATIN, HYPROMELLOSE 2910 (5 MPA.S), POLYETHYLENE GLYCOL 8000, PROPYLENE GLYCOL, SHELLAC, SILICON DIOXIDE, SODIUM LAURYL SULFATE, TALC, TITANIUM DIOXIDE |
| 750 mg extended-release tabletNDC 68382-0861-01 | Polyethylene glycol or polysorbate |
Show 7 ingredientsCELLULOSE, MICROCRYSTALLINE, CROSCARMELLOSE SODIUM, ETHYLCELLULOSE (100 MPA.S), HYPROMELLOSE 2910 (5 MPA.S), POLYETHYLENE GLYCOL 8000, POVIDONE K30, SILICON DIOXIDE |
| 1500 mg extended-release tabletNDC 68382-0740-01 | Polyethylene glycol or polysorbate |
Show 7 ingredientsCELLULOSE, MICROCRYSTALLINE, CROSCARMELLOSE SODIUM, ETHYLCELLULOSE (100 MPA.S), HYPROMELLOSE 2910 (5 MPA.S), POLYETHYLENE GLYCOL 8000, POVIDONE K30, SILICON DIOXIDE |
| Zydus Lifesciences Limited 2 products | ||
| 750 mg extended-release tabletNDC 70771-1599-00 | Polyethylene glycol or polysorbate |
Show 7 ingredientsCELLULOSE, MICROCRYSTALLINE, CROSCARMELLOSE SODIUM, ETHYLCELLULOSE (100 MPA.S), HYPROMELLOSE 2910 (5 MPA.S), POLYETHYLENE GLYCOL 8000, POVIDONE K30, SILICON DIOXIDE |
| 1500 mg extended-release tabletNDC 70771-1600-00 | Still being read | Not read yet |
A product with none of these listed is not certified to be without them: the label says what the manufacturer declared, and the source of a starch or a flavor is often not stated. The companies are the FDA's labelers, which include repackagers and distributors selling another company's product under their own label. The NDC opens the product's own page, with the full label and its inactive-ingredient notes.
Potassium Chloride without a wheat or gluten source
Wheat or gluten source: wheat, barley or rye; a concern with celiac disease or wheat allergy. 4 of 262 checked products list a wheat or gluten source; 258 do not.
Does not list a wheat or gluten source
- A-S Medication Solutions: 10 mEq extended-release capsule, 750 mg extended-release capsule, 10 mEq extended-release tablet, 750 mg extended-release tablet (NDC 50090-6639-00), 750 mg extended-release tablet (NDC 50090-6640-00), 750 mg extended-release tablet (NDC 50090-5335-00), 750 mg extended-release tablet (NDC 50090-7378-00), 750 mg extended-release tablet (NDC 50090-7379-00), 750 mg extended-release tablet (NDC 50090-7639-00), 750 mg extended-release tablet (NDC 50090-7640-00), 750 mg extended-release tablet (NDC 50090-7748-00), 750 mg extended-release tablet (NDC 50090-7749-00), 1500 mg extended-release tablet (NDC 50090-5665-00), 1500 mg extended-release tablet (NDC 50090-6253-00), 1500 mg extended-release tablet (NDC 50090-6866-00), 1500 mg extended-release tablet (NDC 50090-6867-00), 1500 mg extended-release tablet (NDC 50090-7192-00), 1500 mg extended-release tablet (NDC 50090-7193-00), 1500 mg extended-release tablet (NDC 50090-7456-00), 1500 mg extended-release tablet (NDC 50090-7616-00)
- Actavis: 750 mg extended-release capsule, 20 mEq extended-release tablet
- Adare: 600 mg capsule, 750 mg capsule
- Advagen Pharma Limited: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Advagen Pharma Ltd: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Advagen Pharma Ltd.: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Ajenat: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- American Health Packaging: 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution (NDC 60687-0628-07), 1.5 g/15 mL oral solution (NDC 60687-0884-07)
- Amneal Pharmaceuticals LLC: 1.5 g/1.58 g oral solution
- Amneal Pharmaceuticals NY LLC: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Amneal Pharmaceuticals of New York: 750 mg extended-release capsule
- Aphena Pharma Solutions - Tennessee: 750 mg extended-release tablet (NDC 71610-0977-30), 750 mg extended-release tablet (NDC 71610-0935-60), 750 mg extended-release tablet (NDC 71610-0932-60), 750 mg extended-release tablet (NDC 71610-0960-60), 750 mg extended-release tablet (NDC 71610-0945-30), 750 mg extended-release tablet (NDC 71610-0944-30), 750 mg extended-release tablet (NDC 71610-0349-15), 1500 mg extended-release tablet
- Atlantic Biologicals: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Aurobindo: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 59651-0429-01), 750 mg extended-release tablet (NDC 65862-0987-01), 1125 mg extended-release tablet, 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- AvKARE: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 42291-0487-01), 750 mg extended-release tablet (NDC 42291-0506-01), 1500 mg extended-release tablet
- AvPAK: 750 mg extended-release capsule, 3 g/15 mL oral solution
- B. Braun Medical: 14.9 g/100 mL injection
- Baxter Healthcare: 7.46 g/1000 mL injection, 14.9 g/1000 mL injection, 29.8 g/1000 mL injection
- BluePoint: 750 mg extended-release capsule (NDC 68001-0396-00), 750 mg extended-release capsule (NDC 68001-0619-00), 750 mg extended-release tablet
- Bluepoint: 750 mg tablet, 1500 mg tablet
- BPI: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Bryant Ranch Prepack: 600 mg extended-release capsule, 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 63629-1072-01), 750 mg extended-release tablet (NDC 63629-1073-01), 750 mg extended-release tablet (NDC 63629-1074-01), 750 mg extended-release tablet (NDC 63629-1075-01), 750 mg extended-release tablet (NDC 71335-1131-01), 750 mg extended-release tablet (NDC 71335-1900-01), 750 mg extended-release tablet (NDC 71335-2447-01), 750 mg extended-release tablet (NDC 71335-2503-01), 750 mg extended-release tablet (NDC 71335-2607-01), 750 mg extended-release tablet (NDC 71335-2866-01), 750 mg extended-release tablet (NDC 71335-2913-01), 750 mg extended-release tablet (NDC 71335-2958-01), 750 mg extended-release tablet (NDC 72162-1786-00), 1500 mg extended-release tablet (NDC 71335-1896-01), 1500 mg extended-release tablet (NDC 71335-1109-01), 1500 mg extended-release tablet (NDC 71335-1747-01), 1500 mg extended-release tablet (NDC 71335-2045-01)
- Camber: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Cardinal Health 107: 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution
- Carwin Pharmaceutical Associates: 0.75 g/0.79 g oral solution, 1.125 g/1.185 g oral solution, 10 mEq/15 mL oral solution
- Coupler: 750 mg extended-release tablet
- Direct_Rx: 750 mg extended-release tablet (NDC 72189-0648-04), 750 mg extended-release tablet (NDC 72189-0027-04), 1500 mg extended-release tablet
- Endo: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Epic: 600 mg extended-release tablet, 750 mg extended-release tablet
- Fresenius Kabi: 2 mEq/mL injection (NDC 63323-0965-05), 2 mEq/mL injection (NDC 63323-0967-30), 10 mEq/50 mL injection, 10 mEq/100 mL injection, 20 mEq/50 mL injection, 20 mEq/100 mL injection, 40 mEq/100 mL injection
- Genus Lifesciences: 20 mEq/15 mL oral solution
- Genus Lifesciences Inc.: 1.5 g/1.58 g oral solution
- Glenmark: 750 mg extended-release capsule
- Granules India: 600 mg extended-release capsule, 750 mg extended-release capsule, 750 mg tablet, 1500 mg tablet
- Granules Pharmaceuticals Inc: 600 mg extended-release capsule, 750 mg extended-release capsule
- Granules Pharmaceuticals Inc.: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 70010-0136-01), 750 mg extended-release tablet (NDC 70010-0022-01), 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Guardian Drug: 1.5 g/1.57 g oral solution
- Henry Schein: 2 mEq/mL injection, 149 mg/mL injection
- Heritage Pharmaceuticals Inc. d/b/a Avet: 1.5 g/1.58 g oral solution
- HF Acquisition Co LLC, DBA HealthFirst: 149 mg/mL injection (NDC 51662-1421-01), 149 mg/mL injection (NDC 51662-1387-01)
- Hospira: 149 mg/mL injection (NDC 00409-6635-01), 149 mg/mL injection (NDC 00409-6651-06)
- ICU Medical: 10 mEq/100 mL injection, 200 mEq/1000 mL injection, 400 mEq/1000 mL injection
- IPG: 3 g/3.16 g oral solution
- Kesin: 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution, 3 g/30 mL oral solution
- Lupin Pharmaceuticals, Inc.: 10 mEq extended-release capsule
- Lupin Pharmaceuticals,Inc.: 10 mEq extended-release tablet, 20 mEq extended-release tablet, 1.5 g/1.54 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Macleods: 750 mg extended-release tablet, 20 mEq/15 mL oral solution
- Major: 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet (NDC 00904-7547-61), 750 mg extended-release tablet (NDC 00904-7216-61), 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/30 mL oral solution
- Marlex Pharmaceuticals, Inc.: 1.5 g/1.58 g oral solution
- Marlex Pharmaceuticals Inc: 1.5 g/1.58 g oral solution, 3 g/4.75 g oral solution
- Mylan: 8 mEq extended-release tablet, 10 mEq extended-release tablet
- NCS HealthCare of KY, LLC dba Vangard: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 00615-8399-05), 750 mg extended-release tablet (NDC 00615-8570-05), 1500 mg extended-release tablet
- Northstar Rx: 750 mg extended-release capsule, 750 mg extended-release tablet, 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Northwind Health: 750 mg extended-release tablet (NDC 82868-0027-90), 750 mg extended-release tablet (NDC 82868-0111-90), 750 mg extended-release tablet (NDC 51655-0706-52), 750 mg extended-release tablet (NDC 51655-0226-26), 750 mg extended-release tablet (NDC 51655-0463-84), 1500 mg extended-release tablet
- Novel: 1.5 g/1.54 g oral solution
- PAI Holdings, LLC dba PAI: 20 mEq/15 mL oral solution (NDC 00121-0948-16), 20 mEq/15 mL oral solution (NDC 00121-4948-00), 20 mEq/30 mL oral solution, 40 mEq/15 mL oral solution
- PD-Rx: 600 mg extended-release capsule, 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet, 1500 mg extended-release tablet
- Preferred: 1500 mg extended-release tablet
- Proficient Rx: 750 mg extended-release tablet (NDC 82804-0109-30), 750 mg extended-release tablet (NDC 82804-0187-30), 1500 mg extended-release tablet (NDC 71205-0824-03), 1500 mg extended-release tablet (NDC 82804-0057-30)
- Redpharm Drug: 1500 mg extended-release tablet (NDC 67296-2131-02), 1500 mg extended-release tablet (NDC 67296-2160-01), 1500 mg extended-release tablet (NDC 67296-2243-06)
- Remedyrepack: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 70518-3024-01), 750 mg extended-release tablet (NDC 70518-4095-02), 750 mg extended-release tablet (NDC 70518-4520-00), 750 mg extended-release tablet (NDC 70518-2964-00), 1500 mg extended-release tablet
- Rising: 600 mg extended-release tablet, 750 mg extended-release tablet
- Saptalis: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Slate Run: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 70436-0002-01), 750 mg extended-release tablet (NDC 70436-0152-01)
- Solco Healthcare: 600 mg extended-release capsule, 750 mg extended-release capsule, 750 mg tablet, 1125 mg tablet
- Somerset Therapeutics: 1.5 g/1.58 g oral solution
- St. Mary's Medical Park Pharmacy: 750 mg extended-release tablet
- Strides Pharma Science: 600 mg extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Sun: 600 mg extended-release capsule, 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet
- Tris: 20 mEq/15 mL oral solution
- Upsher-Smith: 600 mg extended-release tablet (NDC 24979-0229-00), 600 mg extended-release tablet (NDC 00245-0835-11), 600 mg extended-release tablet (NDC 00245-5315-01), 600 mg extended-release tablet (NDC 00832-5322-10), 750 mg extended-release tablet (NDC 24979-0231-01), 750 mg extended-release tablet (NDC 24979-0230-00), 750 mg extended-release tablet (NDC 00245-5317-01), 750 mg extended-release tablet (NDC 00245-0836-11), 750 mg extended-release tablet (NDC 00245-5316-01), 750 mg extended-release tablet (NDC 00832-5323-10), 1125 mg extended-release tablet, 1500 mg extended-release tablet (NDC 24979-0232-01), 1500 mg extended-release tablet (NDC 00245-5319-01)
- Upsher-SmithLaboratories: 750 mg extended-release tablet, 1500 mg extended-release tablet
- XLCare: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus: 600 mg extended-release capsule, 750 mg extended-release capsule, 750 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus Lifesciences: 750 mg extended-release tablet
Lists a wheat or gluten source
- ANI: 1.5 g/1.56 g oral solution
- Bryant Ranch Prepack: 1.5 g/1.77 g oral solution
- Epic: 1.5 g/1.77 g oral solution
- Upsher-Smith: 1.5 g oral solution
Potassium Chloride without soy
Soy: soybean oil or soy lecithin; a concern with soy allergy. 10 of 262 checked products list soy; 252 do not.
Does not list soy
- A-S Medication Solutions: 10 mEq extended-release capsule, 750 mg extended-release capsule, 10 mEq extended-release tablet, 750 mg extended-release tablet (NDC 50090-6639-00), 750 mg extended-release tablet (NDC 50090-6640-00), 750 mg extended-release tablet (NDC 50090-5335-00), 750 mg extended-release tablet (NDC 50090-7639-00), 750 mg extended-release tablet (NDC 50090-7640-00), 750 mg extended-release tablet (NDC 50090-7748-00), 750 mg extended-release tablet (NDC 50090-7749-00), 1500 mg extended-release tablet (NDC 50090-5665-00), 1500 mg extended-release tablet (NDC 50090-6253-00), 1500 mg extended-release tablet (NDC 50090-6866-00), 1500 mg extended-release tablet (NDC 50090-6867-00), 1500 mg extended-release tablet (NDC 50090-7192-00), 1500 mg extended-release tablet (NDC 50090-7193-00), 1500 mg extended-release tablet (NDC 50090-7456-00), 1500 mg extended-release tablet (NDC 50090-7616-00)
- Actavis: 750 mg extended-release capsule, 20 mEq extended-release tablet
- Adare: 600 mg capsule, 750 mg capsule
- Advagen Pharma Limited: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Advagen Pharma Ltd: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Advagen Pharma Ltd.: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Ajenat: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- American Health Packaging: 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution (NDC 60687-0628-07), 1.5 g/15 mL oral solution (NDC 60687-0884-07)
- Amneal Pharmaceuticals LLC: 1.5 g/1.58 g oral solution
- Amneal Pharmaceuticals NY LLC: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Amneal Pharmaceuticals of New York: 750 mg extended-release capsule
- ANI: 1.5 g/1.56 g oral solution
- Aphena Pharma Solutions - Tennessee: 750 mg extended-release tablet (NDC 71610-0977-30), 750 mg extended-release tablet (NDC 71610-0935-60), 750 mg extended-release tablet (NDC 71610-0932-60), 750 mg extended-release tablet (NDC 71610-0960-60), 750 mg extended-release tablet (NDC 71610-0944-30), 750 mg extended-release tablet (NDC 71610-0349-15), 1500 mg extended-release tablet
- Atlantic Biologicals: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Aurobindo: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 59651-0429-01), 750 mg extended-release tablet (NDC 65862-0987-01), 1125 mg extended-release tablet, 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- AvKARE: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 42291-0487-01), 750 mg extended-release tablet (NDC 42291-0506-01), 1500 mg extended-release tablet
- AvPAK: 750 mg extended-release capsule, 3 g/15 mL oral solution
- B. Braun Medical: 14.9 g/100 mL injection
- Baxter Healthcare: 7.46 g/1000 mL injection, 14.9 g/1000 mL injection, 29.8 g/1000 mL injection
- BluePoint: 750 mg extended-release capsule (NDC 68001-0396-00), 750 mg extended-release capsule (NDC 68001-0619-00), 750 mg extended-release tablet
- Bluepoint: 750 mg tablet, 1500 mg tablet
- BPI: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Bryant Ranch Prepack: 600 mg extended-release capsule, 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 63629-1072-01), 750 mg extended-release tablet (NDC 63629-1073-01), 750 mg extended-release tablet (NDC 63629-1074-01), 750 mg extended-release tablet (NDC 63629-1075-01), 750 mg extended-release tablet (NDC 71335-1131-01), 750 mg extended-release tablet (NDC 71335-1900-01), 750 mg extended-release tablet (NDC 71335-2447-01), 750 mg extended-release tablet (NDC 71335-2503-01), 750 mg extended-release tablet (NDC 71335-2607-01), 750 mg extended-release tablet (NDC 71335-2866-01), 750 mg extended-release tablet (NDC 71335-2913-01), 750 mg extended-release tablet (NDC 71335-2958-01), 750 mg extended-release tablet (NDC 72162-1786-00), 1500 mg extended-release tablet (NDC 71335-1896-01), 1500 mg extended-release tablet (NDC 71335-1109-01), 1500 mg extended-release tablet (NDC 71335-1747-01), 1500 mg extended-release tablet (NDC 71335-2045-01), 1.5 g/1.77 g oral solution
- Camber: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Cardinal Health 107: 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution
- Carwin Pharmaceutical Associates: 0.75 g/0.79 g oral solution, 1.125 g/1.185 g oral solution, 10 mEq/15 mL oral solution
- Coupler: 750 mg extended-release tablet
- Direct_Rx: 750 mg extended-release tablet (NDC 72189-0648-04), 750 mg extended-release tablet (NDC 72189-0027-04), 1500 mg extended-release tablet
- Endo: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Epic: 1.5 g/1.77 g oral solution
- Fresenius Kabi: 2 mEq/mL injection (NDC 63323-0965-05), 2 mEq/mL injection (NDC 63323-0967-30), 10 mEq/50 mL injection, 10 mEq/100 mL injection, 20 mEq/50 mL injection, 20 mEq/100 mL injection, 40 mEq/100 mL injection
- Genus Lifesciences: 20 mEq/15 mL oral solution
- Genus Lifesciences Inc.: 1.5 g/1.58 g oral solution
- Glenmark: 750 mg extended-release capsule
- Granules India: 600 mg extended-release capsule, 750 mg extended-release capsule, 750 mg tablet, 1500 mg tablet
- Granules Pharmaceuticals Inc: 600 mg extended-release capsule, 750 mg extended-release capsule
- Granules Pharmaceuticals Inc.: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 70010-0136-01), 750 mg extended-release tablet (NDC 70010-0022-01), 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Guardian Drug: 1.5 g/1.57 g oral solution
- Henry Schein: 2 mEq/mL injection, 149 mg/mL injection
- Heritage Pharmaceuticals Inc. d/b/a Avet: 1.5 g/1.58 g oral solution
- HF Acquisition Co LLC, DBA HealthFirst: 149 mg/mL injection (NDC 51662-1421-01), 149 mg/mL injection (NDC 51662-1387-01)
- Hospira: 149 mg/mL injection (NDC 00409-6635-01), 149 mg/mL injection (NDC 00409-6651-06)
- ICU Medical: 10 mEq/100 mL injection, 200 mEq/1000 mL injection, 400 mEq/1000 mL injection
- IPG: 3 g/3.16 g oral solution
- Kesin: 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution, 3 g/30 mL oral solution
- Lupin Pharmaceuticals, Inc.: 10 mEq extended-release capsule
- Lupin Pharmaceuticals,Inc.: 10 mEq extended-release tablet, 20 mEq extended-release tablet, 1.5 g/1.54 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Macleods: 750 mg extended-release tablet, 20 mEq/15 mL oral solution
- Major: 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet (NDC 00904-7547-61), 750 mg extended-release tablet (NDC 00904-7216-61), 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/30 mL oral solution
- Marlex Pharmaceuticals, Inc.: 1.5 g/1.58 g oral solution
- Marlex Pharmaceuticals Inc: 1.5 g/1.58 g oral solution, 3 g/4.75 g oral solution
- Mylan: 8 mEq extended-release tablet, 10 mEq extended-release tablet
- NCS HealthCare of KY, LLC dba Vangard: 750 mg extended-release capsule, 750 mg extended-release tablet, 1500 mg extended-release tablet
- Northstar Rx: 750 mg extended-release capsule, 750 mg extended-release tablet, 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Northwind Health: 750 mg extended-release tablet (NDC 82868-0027-90), 750 mg extended-release tablet (NDC 82868-0111-90), 750 mg extended-release tablet (NDC 51655-0706-52), 750 mg extended-release tablet (NDC 51655-0226-26), 750 mg extended-release tablet (NDC 51655-0463-84), 1500 mg extended-release tablet
- Novel: 1.5 g/1.54 g oral solution
- PAI Holdings, LLC dba PAI: 20 mEq/15 mL oral solution (NDC 00121-0948-16), 20 mEq/15 mL oral solution (NDC 00121-4948-00), 20 mEq/30 mL oral solution, 40 mEq/15 mL oral solution
- PD-Rx: 600 mg extended-release capsule, 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet, 1500 mg extended-release tablet
- Preferred: 1500 mg extended-release tablet
- Proficient Rx: 750 mg extended-release tablet, 1500 mg extended-release tablet (NDC 71205-0824-03), 1500 mg extended-release tablet (NDC 82804-0057-30)
- Redpharm Drug: 1500 mg extended-release tablet (NDC 67296-2131-02), 1500 mg extended-release tablet (NDC 67296-2160-01), 1500 mg extended-release tablet (NDC 67296-2243-06)
- Remedyrepack: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 70518-3024-01), 750 mg extended-release tablet (NDC 70518-4095-02), 750 mg extended-release tablet (NDC 70518-4520-00), 750 mg extended-release tablet (NDC 70518-2964-00), 1500 mg extended-release tablet
- Rising: 600 mg extended-release tablet, 750 mg extended-release tablet
- Saptalis: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Slate Run: 750 mg extended-release tablet
- Solco Healthcare: 600 mg extended-release capsule, 750 mg extended-release capsule, 750 mg tablet, 1125 mg tablet
- Somerset Therapeutics: 1.5 g/1.58 g oral solution
- Strides Pharma Science: 600 mg extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Sun: 600 mg extended-release capsule, 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet
- Tris: 20 mEq/15 mL oral solution
- Upsher-Smith: 600 mg extended-release tablet (NDC 24979-0229-00), 600 mg extended-release tablet (NDC 00245-0835-11), 600 mg extended-release tablet (NDC 00245-5315-01), 600 mg extended-release tablet (NDC 00832-5322-10), 750 mg extended-release tablet (NDC 24979-0231-01), 750 mg extended-release tablet (NDC 24979-0230-00), 750 mg extended-release tablet (NDC 00245-5317-01), 750 mg extended-release tablet (NDC 00245-0836-11), 750 mg extended-release tablet (NDC 00245-5316-01), 750 mg extended-release tablet (NDC 00832-5323-10), 1125 mg extended-release tablet, 1500 mg extended-release tablet (NDC 24979-0232-01), 1500 mg extended-release tablet (NDC 00245-5319-01), 1.5 g oral solution
- Upsher-SmithLaboratories: 750 mg extended-release tablet, 1500 mg extended-release tablet
- XLCare: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus: 600 mg extended-release capsule, 750 mg extended-release capsule, 750 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus Lifesciences: 750 mg extended-release tablet
Lists soy
- A-S Medication Solutions: 750 mg extended-release tablet (NDC 50090-7378-00), 750 mg extended-release tablet (NDC 50090-7379-00)
- Aphena Pharma Solutions - Tennessee: 750 mg extended-release tablet
- Epic: 600 mg extended-release tablet, 750 mg extended-release tablet
- NCS HealthCare of KY, LLC dba Vangard: 750 mg extended-release tablet
- Proficient Rx: 750 mg extended-release tablet
- Slate Run: 600 mg extended-release tablet, 750 mg extended-release tablet
- St. Mary's Medical Park Pharmacy: 750 mg extended-release tablet
Potassium Chloride without synthetic dyes
Synthetic dyes: FD&C or D&C colorants and their aluminum lakes. 115 of 262 checked products list synthetic dyes; 147 do not.
Does not list synthetic dyes
- A-S Medication Solutions: 10 mEq extended-release tablet, 750 mg extended-release tablet (NDC 50090-6639-00), 750 mg extended-release tablet (NDC 50090-5335-00), 750 mg extended-release tablet (NDC 50090-7378-00), 750 mg extended-release tablet (NDC 50090-7379-00), 750 mg extended-release tablet (NDC 50090-7748-00), 750 mg extended-release tablet (NDC 50090-7749-00), 1500 mg extended-release tablet (NDC 50090-5665-00), 1500 mg extended-release tablet (NDC 50090-6253-00), 1500 mg extended-release tablet (NDC 50090-6866-00), 1500 mg extended-release tablet (NDC 50090-6867-00), 1500 mg extended-release tablet (NDC 50090-7192-00), 1500 mg extended-release tablet (NDC 50090-7193-00), 1500 mg extended-release tablet (NDC 50090-7456-00), 1500 mg extended-release tablet (NDC 50090-7616-00)
- Actavis: 20 mEq extended-release tablet
- Adare: 600 mg capsule
- Advagen Pharma Ltd: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Advagen Pharma Ltd.: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- American Health Packaging: 20 mEq extended-release tablet, 750 mg extended-release tablet
- Aphena Pharma Solutions - Tennessee: 750 mg extended-release tablet (NDC 71610-0960-60), 750 mg extended-release tablet (NDC 71610-0945-30), 750 mg extended-release tablet (NDC 71610-0944-30), 1500 mg extended-release tablet
- Aurobindo: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 59651-0429-01), 750 mg extended-release tablet (NDC 65862-0987-01), 1125 mg extended-release tablet, 1500 mg extended-release tablet
- AvKARE: 1500 mg extended-release tablet
- B. Braun Medical: 14.9 g/100 mL injection
- Baxter Healthcare: 7.46 g/1000 mL injection, 14.9 g/1000 mL injection, 29.8 g/1000 mL injection
- BluePoint: 750 mg extended-release tablet
- Bluepoint: 750 mg tablet, 1500 mg tablet
- Bryant Ranch Prepack: 600 mg extended-release capsule, 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 63629-1072-01), 750 mg extended-release tablet (NDC 63629-1073-01), 750 mg extended-release tablet (NDC 63629-1074-01), 750 mg extended-release tablet (NDC 63629-1075-01), 750 mg extended-release tablet (NDC 71335-1900-01), 750 mg extended-release tablet (NDC 71335-2503-01), 750 mg extended-release tablet (NDC 71335-2607-01), 750 mg extended-release tablet (NDC 71335-2866-01), 750 mg extended-release tablet (NDC 71335-2913-01), 750 mg extended-release tablet (NDC 71335-2958-01), 750 mg extended-release tablet (NDC 72162-1786-00), 1500 mg extended-release tablet (NDC 71335-1896-01), 1500 mg extended-release tablet (NDC 71335-1109-01), 1500 mg extended-release tablet (NDC 71335-1747-01), 1500 mg extended-release tablet (NDC 71335-2045-01)
- Camber: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Cardinal Health 107: 1500 mg extended-release tablet
- Coupler: 750 mg extended-release tablet
- Direct_Rx: 750 mg extended-release tablet, 1500 mg extended-release tablet
- Epic: 600 mg extended-release tablet, 750 mg extended-release tablet
- Fresenius Kabi: 2 mEq/mL injection (NDC 63323-0965-05), 2 mEq/mL injection (NDC 63323-0967-30), 10 mEq/50 mL injection, 10 mEq/100 mL injection, 20 mEq/50 mL injection, 20 mEq/100 mL injection, 40 mEq/100 mL injection
- Granules India: 600 mg extended-release capsule, 750 mg tablet, 1500 mg tablet
- Granules Pharmaceuticals Inc: 600 mg extended-release capsule
- Granules Pharmaceuticals Inc.: 750 mg extended-release tablet, 1500 mg extended-release tablet
- Henry Schein: 2 mEq/mL injection, 149 mg/mL injection
- HF Acquisition Co LLC, DBA HealthFirst: 149 mg/mL injection (NDC 51662-1421-01), 149 mg/mL injection (NDC 51662-1387-01)
- Hospira: 149 mg/mL injection (NDC 00409-6635-01), 149 mg/mL injection (NDC 00409-6651-06)
- ICU Medical: 10 mEq/100 mL injection, 200 mEq/1000 mL injection, 400 mEq/1000 mL injection
- Lupin Pharmaceuticals,Inc.: 10 mEq extended-release tablet, 20 mEq extended-release tablet
- Macleods: 750 mg extended-release tablet
- Major: 20 mEq extended-release tablet, 750 mg extended-release tablet (NDC 00904-7547-61), 750 mg extended-release tablet (NDC 00904-7216-61), 1500 mg extended-release tablet
- Mylan: 8 mEq extended-release tablet, 10 mEq extended-release tablet
- NCS HealthCare of KY, LLC dba Vangard: 750 mg extended-release tablet (NDC 00615-8399-05), 750 mg extended-release tablet (NDC 00615-8570-05), 1500 mg extended-release tablet
- Northstar Rx: 750 mg extended-release tablet, 1500 mg extended-release tablet
- Northwind Health: 750 mg extended-release tablet (NDC 82868-0027-90), 750 mg extended-release tablet (NDC 51655-0463-84), 1500 mg extended-release tablet
- PD-Rx: 600 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet, 1500 mg extended-release tablet
- Preferred: 1500 mg extended-release tablet
- Proficient Rx: 750 mg extended-release tablet (NDC 82804-0109-30), 750 mg extended-release tablet (NDC 82804-0187-30), 1500 mg extended-release tablet (NDC 71205-0824-03), 1500 mg extended-release tablet (NDC 82804-0057-30)
- Redpharm Drug: 1500 mg extended-release tablet (NDC 67296-2131-02), 1500 mg extended-release tablet (NDC 67296-2160-01), 1500 mg extended-release tablet (NDC 67296-2243-06)
- Remedyrepack: 750 mg extended-release tablet (NDC 70518-3024-01), 750 mg extended-release tablet (NDC 70518-4095-02), 750 mg extended-release tablet (NDC 70518-2964-00), 1500 mg extended-release tablet
- Slate Run: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 70436-0002-01), 750 mg extended-release tablet (NDC 70436-0152-01)
- Solco Healthcare: 600 mg extended-release capsule, 750 mg tablet, 1125 mg tablet
- St. Mary's Medical Park Pharmacy: 750 mg extended-release tablet
- Sun: 600 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet
- Upsher-Smith: 600 mg extended-release tablet (NDC 24979-0229-00), 600 mg extended-release tablet (NDC 00245-0835-11), 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet (NDC 24979-0232-01), 1500 mg extended-release tablet (NDC 00245-5319-01)
- Upsher-SmithLaboratories: 750 mg extended-release tablet, 1500 mg extended-release tablet
- XLCare: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus: 750 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus Lifesciences: 750 mg extended-release tablet
Lists synthetic dyes
- A-S Medication Solutions: 10 mEq extended-release capsule, 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 50090-6640-00), 750 mg extended-release tablet (NDC 50090-7639-00), 750 mg extended-release tablet (NDC 50090-7640-00)
- Actavis: 750 mg extended-release capsule
- Adare: 750 mg capsule
- Advagen Pharma Limited: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Ajenat: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- American Health Packaging: 750 mg extended-release capsule, 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution (NDC 60687-0628-07), 1.5 g/15 mL oral solution (NDC 60687-0884-07)
- Amneal Pharmaceuticals LLC: 1.5 g/1.58 g oral solution
- Amneal Pharmaceuticals NY LLC: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Amneal Pharmaceuticals of New York: 750 mg extended-release capsule
- ANI: 1.5 g/1.56 g oral solution
- Aphena Pharma Solutions - Tennessee: 750 mg extended-release tablet (NDC 71610-0977-30), 750 mg extended-release tablet (NDC 71610-0935-60), 750 mg extended-release tablet (NDC 71610-0932-60), 750 mg extended-release tablet (NDC 71610-0349-15)
- Atlantic Biologicals: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Aurobindo: 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- AvKARE: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 42291-0487-01), 750 mg extended-release tablet (NDC 42291-0506-01)
- AvPAK: 750 mg extended-release capsule, 3 g/15 mL oral solution
- BluePoint: 750 mg extended-release capsule (NDC 68001-0396-00), 750 mg extended-release capsule (NDC 68001-0619-00)
- BPI: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Bryant Ranch Prepack: 750 mg extended-release tablet (NDC 71335-1131-01), 750 mg extended-release tablet (NDC 71335-2447-01), 1.5 g/1.77 g oral solution
- Camber: 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Cardinal Health 107: 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution
- Carwin Pharmaceutical Associates: 0.75 g/0.79 g oral solution, 1.125 g/1.185 g oral solution, 10 mEq/15 mL oral solution
- Direct_Rx: 750 mg extended-release tablet
- Endo: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Epic: 1.5 g/1.77 g oral solution
- Genus Lifesciences: 20 mEq/15 mL oral solution
- Genus Lifesciences Inc.: 1.5 g/1.58 g oral solution
- Glenmark: 750 mg extended-release capsule
- Granules India: 750 mg extended-release capsule
- Granules Pharmaceuticals Inc: 750 mg extended-release capsule
- Granules Pharmaceuticals Inc.: 600 mg extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Guardian Drug: 1.5 g/1.57 g oral solution
- Heritage Pharmaceuticals Inc. d/b/a Avet: 1.5 g/1.58 g oral solution
- IPG: 3 g/3.16 g oral solution
- Kesin: 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution, 3 g/30 mL oral solution
- Lupin Pharmaceuticals, Inc.: 10 mEq extended-release capsule
- Lupin Pharmaceuticals,Inc.: 1.5 g/1.54 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Macleods: 20 mEq/15 mL oral solution
- Major: 750 mg extended-release capsule, 20 mEq/15 mL oral solution, 40 mEq/30 mL oral solution
- Marlex Pharmaceuticals, Inc.: 1.5 g/1.58 g oral solution
- Marlex Pharmaceuticals Inc: 1.5 g/1.58 g oral solution, 3 g/4.75 g oral solution
- NCS HealthCare of KY, LLC dba Vangard: 750 mg extended-release capsule
- Northstar Rx: 750 mg extended-release capsule, 1.5 g/1.58 g oral solution
- Northwind Health: 750 mg extended-release tablet (NDC 82868-0111-90), 750 mg extended-release tablet (NDC 51655-0706-52), 750 mg extended-release tablet (NDC 51655-0226-26)
- Novel: 1.5 g/1.54 g oral solution
- PAI Holdings, LLC dba PAI: 20 mEq/15 mL oral solution (NDC 00121-0948-16), 20 mEq/15 mL oral solution (NDC 00121-4948-00), 20 mEq/30 mL oral solution, 40 mEq/15 mL oral solution
- PD-Rx: 750 mg extended-release capsule
- Remedyrepack: 750 mg extended-release capsule, 750 mg extended-release tablet
- Rising: 600 mg extended-release tablet, 750 mg extended-release tablet
- Saptalis: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Solco Healthcare: 750 mg extended-release capsule
- Somerset Therapeutics: 1.5 g/1.58 g oral solution
- Strides Pharma Science: 600 mg extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Sun: 750 mg extended-release capsule
- Tris: 20 mEq/15 mL oral solution
- Upsher-Smith: 600 mg extended-release tablet (NDC 00245-5315-01), 600 mg extended-release tablet (NDC 00832-5322-10), 750 mg extended-release tablet (NDC 24979-0231-01), 750 mg extended-release tablet (NDC 24979-0230-00), 750 mg extended-release tablet (NDC 00245-0836-11), 750 mg extended-release tablet (NDC 00245-5316-01), 750 mg extended-release tablet (NDC 00832-5323-10), 1.5 g oral solution
- Zydus: 600 mg extended-release capsule, 750 mg extended-release capsule
Potassium Chloride without gelatin
Gelatin: animal-derived (usually bovine or porcine); a concern for vegetarian, kosher or halal needs. 28 of 262 checked products list gelatin; 234 do not.
Does not list gelatin
- A-S Medication Solutions: 10 mEq extended-release tablet, 750 mg extended-release tablet (NDC 50090-6639-00), 750 mg extended-release tablet (NDC 50090-6640-00), 750 mg extended-release tablet (NDC 50090-5335-00), 750 mg extended-release tablet (NDC 50090-7378-00), 750 mg extended-release tablet (NDC 50090-7379-00), 750 mg extended-release tablet (NDC 50090-7639-00), 750 mg extended-release tablet (NDC 50090-7640-00), 750 mg extended-release tablet (NDC 50090-7748-00), 750 mg extended-release tablet (NDC 50090-7749-00), 1500 mg extended-release tablet (NDC 50090-5665-00), 1500 mg extended-release tablet (NDC 50090-6253-00), 1500 mg extended-release tablet (NDC 50090-6866-00), 1500 mg extended-release tablet (NDC 50090-6867-00), 1500 mg extended-release tablet (NDC 50090-7192-00), 1500 mg extended-release tablet (NDC 50090-7193-00), 1500 mg extended-release tablet (NDC 50090-7456-00), 1500 mg extended-release tablet (NDC 50090-7616-00)
- Actavis: 750 mg extended-release capsule, 20 mEq extended-release tablet
- Advagen Pharma Limited: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Advagen Pharma Ltd: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Advagen Pharma Ltd.: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Ajenat: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- American Health Packaging: 20 mEq extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution (NDC 60687-0628-07), 1.5 g/15 mL oral solution (NDC 60687-0884-07)
- Amneal Pharmaceuticals LLC: 1.5 g/1.58 g oral solution
- Amneal Pharmaceuticals NY LLC: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- ANI: 1.5 g/1.56 g oral solution
- Aphena Pharma Solutions - Tennessee: 750 mg extended-release tablet (NDC 71610-0977-30), 750 mg extended-release tablet (NDC 71610-0935-60), 750 mg extended-release tablet (NDC 71610-0932-60), 750 mg extended-release tablet (NDC 71610-0960-60), 750 mg extended-release tablet (NDC 71610-0945-30), 750 mg extended-release tablet (NDC 71610-0944-30), 750 mg extended-release tablet (NDC 71610-0349-15), 1500 mg extended-release tablet
- Atlantic Biologicals: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Aurobindo: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 59651-0429-01), 750 mg extended-release tablet (NDC 65862-0987-01), 1125 mg extended-release tablet, 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- AvKARE: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 42291-0487-01), 750 mg extended-release tablet (NDC 42291-0506-01), 1500 mg extended-release tablet
- AvPAK: 3 g/15 mL oral solution
- B. Braun Medical: 14.9 g/100 mL injection
- Baxter Healthcare: 7.46 g/1000 mL injection, 14.9 g/1000 mL injection, 29.8 g/1000 mL injection
- BluePoint: 750 mg extended-release tablet
- Bluepoint: 750 mg tablet, 1500 mg tablet
- BPI: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Bryant Ranch Prepack: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 63629-1072-01), 750 mg extended-release tablet (NDC 63629-1073-01), 750 mg extended-release tablet (NDC 63629-1074-01), 750 mg extended-release tablet (NDC 63629-1075-01), 750 mg extended-release tablet (NDC 71335-1131-01), 750 mg extended-release tablet (NDC 71335-1900-01), 750 mg extended-release tablet (NDC 71335-2447-01), 750 mg extended-release tablet (NDC 71335-2503-01), 750 mg extended-release tablet (NDC 71335-2607-01), 750 mg extended-release tablet (NDC 71335-2866-01), 750 mg extended-release tablet (NDC 71335-2913-01), 750 mg extended-release tablet (NDC 71335-2958-01), 750 mg extended-release tablet (NDC 72162-1786-00), 1500 mg extended-release tablet (NDC 71335-1896-01), 1500 mg extended-release tablet (NDC 71335-1109-01), 1500 mg extended-release tablet (NDC 71335-1747-01), 1500 mg extended-release tablet (NDC 71335-2045-01), 1.5 g/1.77 g oral solution
- Camber: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Cardinal Health 107: 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution
- Carwin Pharmaceutical Associates: 0.75 g/0.79 g oral solution, 1.125 g/1.185 g oral solution, 10 mEq/15 mL oral solution
- Coupler: 750 mg extended-release tablet
- Direct_Rx: 750 mg extended-release tablet (NDC 72189-0648-04), 750 mg extended-release tablet (NDC 72189-0027-04), 1500 mg extended-release tablet
- Endo: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Epic: 600 mg extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.77 g oral solution
- Fresenius Kabi: 2 mEq/mL injection (NDC 63323-0965-05), 2 mEq/mL injection (NDC 63323-0967-30), 10 mEq/50 mL injection, 10 mEq/100 mL injection, 20 mEq/50 mL injection, 20 mEq/100 mL injection, 40 mEq/100 mL injection
- Genus Lifesciences: 20 mEq/15 mL oral solution
- Genus Lifesciences Inc.: 1.5 g/1.58 g oral solution
- Granules India: 750 mg tablet, 1500 mg tablet
- Granules Pharmaceuticals Inc.: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 70010-0136-01), 750 mg extended-release tablet (NDC 70010-0022-01), 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Guardian Drug: 1.5 g/1.57 g oral solution
- Henry Schein: 2 mEq/mL injection, 149 mg/mL injection
- Heritage Pharmaceuticals Inc. d/b/a Avet: 1.5 g/1.58 g oral solution
- HF Acquisition Co LLC, DBA HealthFirst: 149 mg/mL injection (NDC 51662-1421-01), 149 mg/mL injection (NDC 51662-1387-01)
- Hospira: 149 mg/mL injection (NDC 00409-6635-01), 149 mg/mL injection (NDC 00409-6651-06)
- ICU Medical: 10 mEq/100 mL injection, 200 mEq/1000 mL injection, 400 mEq/1000 mL injection
- IPG: 3 g/3.16 g oral solution
- Kesin: 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution, 3 g/30 mL oral solution
- Lupin Pharmaceuticals,Inc.: 10 mEq extended-release tablet, 20 mEq extended-release tablet, 1.5 g/1.54 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Macleods: 750 mg extended-release tablet, 20 mEq/15 mL oral solution
- Major: 20 mEq extended-release tablet, 750 mg extended-release tablet (NDC 00904-7547-61), 750 mg extended-release tablet (NDC 00904-7216-61), 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/30 mL oral solution
- Marlex Pharmaceuticals, Inc.: 1.5 g/1.58 g oral solution
- Marlex Pharmaceuticals Inc: 1.5 g/1.58 g oral solution, 3 g/4.75 g oral solution
- Mylan: 8 mEq extended-release tablet, 10 mEq extended-release tablet
- NCS HealthCare of KY, LLC dba Vangard: 750 mg extended-release tablet (NDC 00615-8399-05), 750 mg extended-release tablet (NDC 00615-8570-05), 1500 mg extended-release tablet
- Northstar Rx: 750 mg extended-release tablet, 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Northwind Health: 750 mg extended-release tablet (NDC 82868-0027-90), 750 mg extended-release tablet (NDC 82868-0111-90), 750 mg extended-release tablet (NDC 51655-0706-52), 750 mg extended-release tablet (NDC 51655-0226-26), 750 mg extended-release tablet (NDC 51655-0463-84), 1500 mg extended-release tablet
- Novel: 1.5 g/1.54 g oral solution
- PAI Holdings, LLC dba PAI: 20 mEq/15 mL oral solution (NDC 00121-0948-16), 20 mEq/15 mL oral solution (NDC 00121-4948-00), 20 mEq/30 mL oral solution, 40 mEq/15 mL oral solution
- PD-Rx: 20 mEq extended-release tablet, 750 mg extended-release tablet, 1500 mg extended-release tablet
- Preferred: 1500 mg extended-release tablet
- Proficient Rx: 750 mg extended-release tablet (NDC 82804-0109-30), 750 mg extended-release tablet (NDC 82804-0187-30), 1500 mg extended-release tablet (NDC 71205-0824-03), 1500 mg extended-release tablet (NDC 82804-0057-30)
- Redpharm Drug: 1500 mg extended-release tablet (NDC 67296-2131-02), 1500 mg extended-release tablet (NDC 67296-2160-01), 1500 mg extended-release tablet (NDC 67296-2243-06)
- Remedyrepack: 750 mg extended-release tablet (NDC 70518-3024-01), 750 mg extended-release tablet (NDC 70518-4095-02), 750 mg extended-release tablet (NDC 70518-4520-00), 750 mg extended-release tablet (NDC 70518-2964-00), 1500 mg extended-release tablet
- Rising: 600 mg extended-release tablet, 750 mg extended-release tablet
- Saptalis: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Slate Run: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 70436-0002-01), 750 mg extended-release tablet (NDC 70436-0152-01)
- Solco Healthcare: 750 mg tablet, 1125 mg tablet
- Somerset Therapeutics: 1.5 g/1.58 g oral solution
- St. Mary's Medical Park Pharmacy: 750 mg extended-release tablet
- Strides Pharma Science: 600 mg extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Sun: 20 mEq extended-release tablet, 750 mg extended-release tablet
- Tris: 20 mEq/15 mL oral solution
- Upsher-Smith: 600 mg extended-release tablet (NDC 24979-0229-00), 600 mg extended-release tablet (NDC 00245-0835-11), 600 mg extended-release tablet (NDC 00245-5315-01), 600 mg extended-release tablet (NDC 00832-5322-10), 750 mg extended-release tablet (NDC 24979-0231-01), 750 mg extended-release tablet (NDC 24979-0230-00), 750 mg extended-release tablet (NDC 00245-5317-01), 750 mg extended-release tablet (NDC 00245-0836-11), 750 mg extended-release tablet (NDC 00245-5316-01), 750 mg extended-release tablet (NDC 00832-5323-10), 1125 mg extended-release tablet, 1500 mg extended-release tablet (NDC 24979-0232-01), 1500 mg extended-release tablet (NDC 00245-5319-01), 1.5 g oral solution
- Upsher-SmithLaboratories: 750 mg extended-release tablet, 1500 mg extended-release tablet
- XLCare: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus: 750 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus Lifesciences: 750 mg extended-release tablet
Lists gelatin
- A-S Medication Solutions: 10 mEq extended-release capsule, 750 mg extended-release capsule
- Adare: 600 mg capsule, 750 mg capsule
- American Health Packaging: 750 mg extended-release capsule
- Amneal Pharmaceuticals of New York: 750 mg extended-release capsule
- AvPAK: 750 mg extended-release capsule
- BluePoint: 750 mg extended-release capsule (NDC 68001-0396-00), 750 mg extended-release capsule (NDC 68001-0619-00)
- Bryant Ranch Prepack: 600 mg extended-release capsule
- Glenmark: 750 mg extended-release capsule
- Granules India: 600 mg extended-release capsule, 750 mg extended-release capsule
- Granules Pharmaceuticals Inc: 600 mg extended-release capsule, 750 mg extended-release capsule
- Lupin Pharmaceuticals, Inc.: 10 mEq extended-release capsule
- Major: 750 mg extended-release capsule
- NCS HealthCare of KY, LLC dba Vangard: 750 mg extended-release capsule
- Northstar Rx: 750 mg extended-release capsule
- PD-Rx: 600 mg extended-release capsule, 750 mg extended-release capsule
- Remedyrepack: 750 mg extended-release capsule
- Solco Healthcare: 600 mg extended-release capsule, 750 mg extended-release capsule
- Sun: 600 mg extended-release capsule, 750 mg extended-release capsule
- Zydus: 600 mg extended-release capsule, 750 mg extended-release capsule
Potassium Chloride without corn-derived ingredients
Corn-derived: corn starch, maize or corn syrup; a concern with corn allergy. 3 of 262 checked products list corn-derived ingredients; 259 do not.
Does not list corn-derived ingredients
- A-S Medication Solutions: 10 mEq extended-release capsule, 750 mg extended-release capsule, 10 mEq extended-release tablet, 750 mg extended-release tablet (NDC 50090-6639-00), 750 mg extended-release tablet (NDC 50090-6640-00), 750 mg extended-release tablet (NDC 50090-5335-00), 750 mg extended-release tablet (NDC 50090-7378-00), 750 mg extended-release tablet (NDC 50090-7379-00), 750 mg extended-release tablet (NDC 50090-7639-00), 750 mg extended-release tablet (NDC 50090-7640-00), 750 mg extended-release tablet (NDC 50090-7748-00), 750 mg extended-release tablet (NDC 50090-7749-00), 1500 mg extended-release tablet (NDC 50090-5665-00), 1500 mg extended-release tablet (NDC 50090-6253-00), 1500 mg extended-release tablet (NDC 50090-6866-00), 1500 mg extended-release tablet (NDC 50090-6867-00), 1500 mg extended-release tablet (NDC 50090-7192-00), 1500 mg extended-release tablet (NDC 50090-7193-00), 1500 mg extended-release tablet (NDC 50090-7456-00), 1500 mg extended-release tablet (NDC 50090-7616-00)
- Actavis: 750 mg extended-release capsule, 20 mEq extended-release tablet
- Adare: 600 mg capsule, 750 mg capsule
- Advagen Pharma Limited: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Advagen Pharma Ltd: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Advagen Pharma Ltd.: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Ajenat: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- American Health Packaging: 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution (NDC 60687-0628-07), 1.5 g/15 mL oral solution (NDC 60687-0884-07)
- Amneal Pharmaceuticals LLC: 1.5 g/1.58 g oral solution
- Amneal Pharmaceuticals NY LLC: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Amneal Pharmaceuticals of New York: 750 mg extended-release capsule
- ANI: 1.5 g/1.56 g oral solution
- Aphena Pharma Solutions - Tennessee: 750 mg extended-release tablet (NDC 71610-0977-30), 750 mg extended-release tablet (NDC 71610-0935-60), 750 mg extended-release tablet (NDC 71610-0932-60), 750 mg extended-release tablet (NDC 71610-0960-60), 750 mg extended-release tablet (NDC 71610-0945-30), 750 mg extended-release tablet (NDC 71610-0944-30), 750 mg extended-release tablet (NDC 71610-0349-15), 1500 mg extended-release tablet
- Atlantic Biologicals: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Aurobindo: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 59651-0429-01), 750 mg extended-release tablet (NDC 65862-0987-01), 1125 mg extended-release tablet, 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- AvKARE: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 42291-0487-01), 750 mg extended-release tablet (NDC 42291-0506-01), 1500 mg extended-release tablet
- AvPAK: 750 mg extended-release capsule, 3 g/15 mL oral solution
- B. Braun Medical: 14.9 g/100 mL injection
- Baxter Healthcare: 7.46 g/1000 mL injection, 14.9 g/1000 mL injection, 29.8 g/1000 mL injection
- BluePoint: 750 mg extended-release capsule (NDC 68001-0396-00), 750 mg extended-release capsule (NDC 68001-0619-00), 750 mg extended-release tablet
- Bluepoint: 750 mg tablet, 1500 mg tablet
- BPI: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Bryant Ranch Prepack: 600 mg extended-release capsule, 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 63629-1072-01), 750 mg extended-release tablet (NDC 63629-1073-01), 750 mg extended-release tablet (NDC 63629-1074-01), 750 mg extended-release tablet (NDC 63629-1075-01), 750 mg extended-release tablet (NDC 71335-1131-01), 750 mg extended-release tablet (NDC 71335-1900-01), 750 mg extended-release tablet (NDC 71335-2447-01), 750 mg extended-release tablet (NDC 71335-2503-01), 750 mg extended-release tablet (NDC 71335-2607-01), 750 mg extended-release tablet (NDC 71335-2866-01), 750 mg extended-release tablet (NDC 71335-2913-01), 750 mg extended-release tablet (NDC 71335-2958-01), 750 mg extended-release tablet (NDC 72162-1786-00), 1500 mg extended-release tablet (NDC 71335-1896-01), 1500 mg extended-release tablet (NDC 71335-1109-01), 1500 mg extended-release tablet (NDC 71335-1747-01), 1500 mg extended-release tablet (NDC 71335-2045-01), 1.5 g/1.77 g oral solution
- Camber: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Cardinal Health 107: 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution
- Carwin Pharmaceutical Associates: 0.75 g/0.79 g oral solution, 1.125 g/1.185 g oral solution, 10 mEq/15 mL oral solution
- Coupler: 750 mg extended-release tablet
- Direct_Rx: 750 mg extended-release tablet (NDC 72189-0648-04), 750 mg extended-release tablet (NDC 72189-0027-04), 1500 mg extended-release tablet
- Endo: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Epic: 600 mg extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.77 g oral solution
- Fresenius Kabi: 2 mEq/mL injection (NDC 63323-0965-05), 2 mEq/mL injection (NDC 63323-0967-30), 10 mEq/50 mL injection, 10 mEq/100 mL injection, 20 mEq/50 mL injection, 20 mEq/100 mL injection, 40 mEq/100 mL injection
- Genus Lifesciences: 20 mEq/15 mL oral solution
- Genus Lifesciences Inc.: 1.5 g/1.58 g oral solution
- Glenmark: 750 mg extended-release capsule
- Granules India: 600 mg extended-release capsule, 750 mg extended-release capsule, 750 mg tablet, 1500 mg tablet
- Granules Pharmaceuticals Inc: 600 mg extended-release capsule, 750 mg extended-release capsule
- Granules Pharmaceuticals Inc.: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 70010-0136-01), 750 mg extended-release tablet (NDC 70010-0022-01), 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Guardian Drug: 1.5 g/1.57 g oral solution
- Henry Schein: 2 mEq/mL injection, 149 mg/mL injection
- Heritage Pharmaceuticals Inc. d/b/a Avet: 1.5 g/1.58 g oral solution
- HF Acquisition Co LLC, DBA HealthFirst: 149 mg/mL injection (NDC 51662-1421-01), 149 mg/mL injection (NDC 51662-1387-01)
- Hospira: 149 mg/mL injection (NDC 00409-6635-01), 149 mg/mL injection (NDC 00409-6651-06)
- ICU Medical: 10 mEq/100 mL injection, 200 mEq/1000 mL injection, 400 mEq/1000 mL injection
- IPG: 3 g/3.16 g oral solution
- Kesin: 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution, 3 g/30 mL oral solution
- Lupin Pharmaceuticals, Inc.: 10 mEq extended-release capsule
- Lupin Pharmaceuticals,Inc.: 10 mEq extended-release tablet, 20 mEq extended-release tablet, 1.5 g/1.54 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Macleods: 750 mg extended-release tablet, 20 mEq/15 mL oral solution
- Major: 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet (NDC 00904-7547-61), 750 mg extended-release tablet (NDC 00904-7216-61), 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/30 mL oral solution
- Marlex Pharmaceuticals, Inc.: 1.5 g/1.58 g oral solution
- Marlex Pharmaceuticals Inc: 1.5 g/1.58 g oral solution, 3 g/4.75 g oral solution
- Mylan: 8 mEq extended-release tablet, 10 mEq extended-release tablet
- NCS HealthCare of KY, LLC dba Vangard: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 00615-8399-05), 750 mg extended-release tablet (NDC 00615-8570-05), 1500 mg extended-release tablet
- Northstar Rx: 750 mg extended-release capsule, 750 mg extended-release tablet, 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Northwind Health: 750 mg extended-release tablet (NDC 82868-0027-90), 750 mg extended-release tablet (NDC 82868-0111-90), 750 mg extended-release tablet (NDC 51655-0706-52), 750 mg extended-release tablet (NDC 51655-0226-26), 750 mg extended-release tablet (NDC 51655-0463-84), 1500 mg extended-release tablet
- Novel: 1.5 g/1.54 g oral solution
- PAI Holdings, LLC dba PAI: 20 mEq/15 mL oral solution (NDC 00121-0948-16), 20 mEq/15 mL oral solution (NDC 00121-4948-00), 20 mEq/30 mL oral solution, 40 mEq/15 mL oral solution
- PD-Rx: 600 mg extended-release capsule, 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet, 1500 mg extended-release tablet
- Preferred: 1500 mg extended-release tablet
- Proficient Rx: 750 mg extended-release tablet (NDC 82804-0109-30), 750 mg extended-release tablet (NDC 82804-0187-30), 1500 mg extended-release tablet (NDC 71205-0824-03), 1500 mg extended-release tablet (NDC 82804-0057-30)
- Redpharm Drug: 1500 mg extended-release tablet (NDC 67296-2131-02), 1500 mg extended-release tablet (NDC 67296-2160-01), 1500 mg extended-release tablet (NDC 67296-2243-06)
- Remedyrepack: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 70518-3024-01), 750 mg extended-release tablet (NDC 70518-4095-02), 750 mg extended-release tablet (NDC 70518-4520-00), 750 mg extended-release tablet (NDC 70518-2964-00), 1500 mg extended-release tablet
- Rising: 600 mg extended-release tablet, 750 mg extended-release tablet
- Saptalis: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Slate Run: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 70436-0002-01), 750 mg extended-release tablet (NDC 70436-0152-01)
- Solco Healthcare: 600 mg extended-release capsule, 750 mg extended-release capsule, 750 mg tablet, 1125 mg tablet
- Somerset Therapeutics: 1.5 g/1.58 g oral solution
- St. Mary's Medical Park Pharmacy: 750 mg extended-release tablet
- Strides Pharma Science: 600 mg extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Sun: 600 mg extended-release capsule, 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet
- Tris: 20 mEq/15 mL oral solution
- Upsher-Smith: 600 mg extended-release tablet (NDC 24979-0229-00), 600 mg extended-release tablet (NDC 00245-0835-11), 600 mg extended-release tablet (NDC 00245-5315-01), 600 mg extended-release tablet (NDC 00832-5322-10), 750 mg extended-release tablet (NDC 24979-0231-01), 750 mg extended-release tablet (NDC 24979-0230-00), 750 mg extended-release tablet (NDC 00245-5317-01), 750 mg extended-release tablet (NDC 00245-0836-11), 750 mg extended-release tablet (NDC 00245-5316-01), 750 mg extended-release tablet (NDC 00832-5323-10), 1125 mg extended-release tablet, 1500 mg extended-release tablet (NDC 24979-0232-01), 1500 mg extended-release tablet (NDC 00245-5319-01)
- Upsher-SmithLaboratories: 750 mg extended-release tablet, 1500 mg extended-release tablet
- XLCare: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus: 600 mg extended-release capsule, 750 mg extended-release capsule, 750 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus Lifesciences: 750 mg extended-release tablet
Lists corn-derived ingredients
- Camber: 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Upsher-Smith: 1.5 g oral solution
Potassium Chloride without tartrazine (FD&C Yellow No. 5)
Tartrazine (FD&C Yellow No. 5): flagged separately: labels must warn about it, and it can cause reactions in people sensitive to aspirin. 4 of 262 checked products list tartrazine (FD&C Yellow No. 5); 258 do not.
Does not list tartrazine (FD&C Yellow No. 5)
- A-S Medication Solutions: 10 mEq extended-release capsule, 750 mg extended-release capsule, 10 mEq extended-release tablet, 750 mg extended-release tablet (NDC 50090-6639-00), 750 mg extended-release tablet (NDC 50090-6640-00), 750 mg extended-release tablet (NDC 50090-5335-00), 750 mg extended-release tablet (NDC 50090-7378-00), 750 mg extended-release tablet (NDC 50090-7379-00), 750 mg extended-release tablet (NDC 50090-7639-00), 750 mg extended-release tablet (NDC 50090-7640-00), 750 mg extended-release tablet (NDC 50090-7748-00), 750 mg extended-release tablet (NDC 50090-7749-00), 1500 mg extended-release tablet (NDC 50090-5665-00), 1500 mg extended-release tablet (NDC 50090-6253-00), 1500 mg extended-release tablet (NDC 50090-6866-00), 1500 mg extended-release tablet (NDC 50090-6867-00), 1500 mg extended-release tablet (NDC 50090-7192-00), 1500 mg extended-release tablet (NDC 50090-7193-00), 1500 mg extended-release tablet (NDC 50090-7456-00), 1500 mg extended-release tablet (NDC 50090-7616-00)
- Actavis: 750 mg extended-release capsule, 20 mEq extended-release tablet
- Adare: 600 mg capsule, 750 mg capsule
- Advagen Pharma Limited: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Advagen Pharma Ltd: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Advagen Pharma Ltd.: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Ajenat: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- American Health Packaging: 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution (NDC 60687-0628-07), 1.5 g/15 mL oral solution (NDC 60687-0884-07)
- Amneal Pharmaceuticals LLC: 1.5 g/1.58 g oral solution
- Amneal Pharmaceuticals NY LLC: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Amneal Pharmaceuticals of New York: 750 mg extended-release capsule
- ANI: 1.5 g/1.56 g oral solution
- Aphena Pharma Solutions - Tennessee: 750 mg extended-release tablet (NDC 71610-0977-30), 750 mg extended-release tablet (NDC 71610-0935-60), 750 mg extended-release tablet (NDC 71610-0932-60), 750 mg extended-release tablet (NDC 71610-0960-60), 750 mg extended-release tablet (NDC 71610-0945-30), 750 mg extended-release tablet (NDC 71610-0944-30), 750 mg extended-release tablet (NDC 71610-0349-15), 1500 mg extended-release tablet
- Atlantic Biologicals: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Aurobindo: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 59651-0429-01), 750 mg extended-release tablet (NDC 65862-0987-01), 1125 mg extended-release tablet, 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- AvKARE: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 42291-0487-01), 750 mg extended-release tablet (NDC 42291-0506-01), 1500 mg extended-release tablet
- AvPAK: 750 mg extended-release capsule, 3 g/15 mL oral solution
- B. Braun Medical: 14.9 g/100 mL injection
- Baxter Healthcare: 7.46 g/1000 mL injection, 14.9 g/1000 mL injection, 29.8 g/1000 mL injection
- BluePoint: 750 mg extended-release capsule (NDC 68001-0396-00), 750 mg extended-release capsule (NDC 68001-0619-00), 750 mg extended-release tablet
- Bluepoint: 750 mg tablet, 1500 mg tablet
- BPI: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Bryant Ranch Prepack: 600 mg extended-release capsule, 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 63629-1072-01), 750 mg extended-release tablet (NDC 63629-1073-01), 750 mg extended-release tablet (NDC 63629-1074-01), 750 mg extended-release tablet (NDC 63629-1075-01), 750 mg extended-release tablet (NDC 71335-1900-01), 750 mg extended-release tablet (NDC 71335-2447-01), 750 mg extended-release tablet (NDC 71335-2503-01), 750 mg extended-release tablet (NDC 71335-2607-01), 750 mg extended-release tablet (NDC 71335-2866-01), 750 mg extended-release tablet (NDC 71335-2913-01), 750 mg extended-release tablet (NDC 71335-2958-01), 750 mg extended-release tablet (NDC 72162-1786-00), 1500 mg extended-release tablet (NDC 71335-1896-01), 1500 mg extended-release tablet (NDC 71335-1109-01), 1500 mg extended-release tablet (NDC 71335-1747-01), 1500 mg extended-release tablet (NDC 71335-2045-01), 1.5 g/1.77 g oral solution
- Camber: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Cardinal Health 107: 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution
- Carwin Pharmaceutical Associates: 0.75 g/0.79 g oral solution, 1.125 g/1.185 g oral solution, 10 mEq/15 mL oral solution
- Coupler: 750 mg extended-release tablet
- Direct_Rx: 750 mg extended-release tablet, 1500 mg extended-release tablet
- Endo: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Epic: 600 mg extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.77 g oral solution
- Fresenius Kabi: 2 mEq/mL injection (NDC 63323-0965-05), 2 mEq/mL injection (NDC 63323-0967-30), 10 mEq/50 mL injection, 10 mEq/100 mL injection, 20 mEq/50 mL injection, 20 mEq/100 mL injection, 40 mEq/100 mL injection
- Genus Lifesciences: 20 mEq/15 mL oral solution
- Genus Lifesciences Inc.: 1.5 g/1.58 g oral solution
- Glenmark: 750 mg extended-release capsule
- Granules India: 600 mg extended-release capsule, 750 mg extended-release capsule, 750 mg tablet, 1500 mg tablet
- Granules Pharmaceuticals Inc: 600 mg extended-release capsule, 750 mg extended-release capsule
- Granules Pharmaceuticals Inc.: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 70010-0136-01), 750 mg extended-release tablet (NDC 70010-0022-01), 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Guardian Drug: 1.5 g/1.57 g oral solution
- Henry Schein: 2 mEq/mL injection, 149 mg/mL injection
- Heritage Pharmaceuticals Inc. d/b/a Avet: 1.5 g/1.58 g oral solution
- HF Acquisition Co LLC, DBA HealthFirst: 149 mg/mL injection (NDC 51662-1421-01), 149 mg/mL injection (NDC 51662-1387-01)
- Hospira: 149 mg/mL injection (NDC 00409-6635-01), 149 mg/mL injection (NDC 00409-6651-06)
- ICU Medical: 10 mEq/100 mL injection, 200 mEq/1000 mL injection, 400 mEq/1000 mL injection
- IPG: 3 g/3.16 g oral solution
- Kesin: 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution, 3 g/30 mL oral solution
- Lupin Pharmaceuticals, Inc.: 10 mEq extended-release capsule
- Lupin Pharmaceuticals,Inc.: 10 mEq extended-release tablet, 20 mEq extended-release tablet, 1.5 g/1.54 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Macleods: 750 mg extended-release tablet, 20 mEq/15 mL oral solution
- Major: 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet (NDC 00904-7547-61), 750 mg extended-release tablet (NDC 00904-7216-61), 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/30 mL oral solution
- Marlex Pharmaceuticals, Inc.: 1.5 g/1.58 g oral solution
- Marlex Pharmaceuticals Inc: 1.5 g/1.58 g oral solution, 3 g/4.75 g oral solution
- Mylan: 8 mEq extended-release tablet, 10 mEq extended-release tablet
- NCS HealthCare of KY, LLC dba Vangard: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 00615-8399-05), 750 mg extended-release tablet (NDC 00615-8570-05), 1500 mg extended-release tablet
- Northstar Rx: 750 mg extended-release capsule, 750 mg extended-release tablet, 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Northwind Health: 750 mg extended-release tablet (NDC 82868-0027-90), 750 mg extended-release tablet (NDC 82868-0111-90), 750 mg extended-release tablet (NDC 51655-0226-26), 750 mg extended-release tablet (NDC 51655-0463-84), 1500 mg extended-release tablet
- Novel: 1.5 g/1.54 g oral solution
- PAI Holdings, LLC dba PAI: 20 mEq/15 mL oral solution (NDC 00121-0948-16), 20 mEq/15 mL oral solution (NDC 00121-4948-00), 20 mEq/30 mL oral solution, 40 mEq/15 mL oral solution
- PD-Rx: 600 mg extended-release capsule, 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet, 1500 mg extended-release tablet
- Preferred: 1500 mg extended-release tablet
- Proficient Rx: 750 mg extended-release tablet (NDC 82804-0109-30), 750 mg extended-release tablet (NDC 82804-0187-30), 1500 mg extended-release tablet (NDC 71205-0824-03), 1500 mg extended-release tablet (NDC 82804-0057-30)
- Redpharm Drug: 1500 mg extended-release tablet (NDC 67296-2131-02), 1500 mg extended-release tablet (NDC 67296-2160-01), 1500 mg extended-release tablet (NDC 67296-2243-06)
- Remedyrepack: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 70518-3024-01), 750 mg extended-release tablet (NDC 70518-4095-02), 750 mg extended-release tablet (NDC 70518-4520-00), 750 mg extended-release tablet (NDC 70518-2964-00), 1500 mg extended-release tablet
- Rising: 600 mg extended-release tablet, 750 mg extended-release tablet
- Saptalis: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Slate Run: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 70436-0002-01), 750 mg extended-release tablet (NDC 70436-0152-01)
- Solco Healthcare: 600 mg extended-release capsule, 750 mg extended-release capsule, 750 mg tablet, 1125 mg tablet
- Somerset Therapeutics: 1.5 g/1.58 g oral solution
- St. Mary's Medical Park Pharmacy: 750 mg extended-release tablet
- Strides Pharma Science: 600 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Sun: 600 mg extended-release capsule, 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet
- Tris: 20 mEq/15 mL oral solution
- Upsher-Smith: 600 mg extended-release tablet (NDC 24979-0229-00), 600 mg extended-release tablet (NDC 00245-0835-11), 600 mg extended-release tablet (NDC 00245-5315-01), 600 mg extended-release tablet (NDC 00832-5322-10), 750 mg extended-release tablet (NDC 24979-0231-01), 750 mg extended-release tablet (NDC 24979-0230-00), 750 mg extended-release tablet (NDC 00245-5317-01), 750 mg extended-release tablet (NDC 00245-0836-11), 750 mg extended-release tablet (NDC 00245-5316-01), 750 mg extended-release tablet (NDC 00832-5323-10), 1125 mg extended-release tablet, 1500 mg extended-release tablet (NDC 24979-0232-01), 1500 mg extended-release tablet (NDC 00245-5319-01), 1.5 g oral solution
- Upsher-SmithLaboratories: 750 mg extended-release tablet, 1500 mg extended-release tablet
- XLCare: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus: 600 mg extended-release capsule, 750 mg extended-release capsule, 750 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus Lifesciences: 750 mg extended-release tablet
Lists tartrazine (FD&C Yellow No. 5)
- Bryant Ranch Prepack: 750 mg extended-release tablet
- Direct_Rx: 750 mg extended-release tablet
- Northwind Health: 750 mg extended-release tablet
- Strides Pharma Science: 750 mg extended-release tablet
Potassium Chloride without titanium dioxide
Titanium dioxide: A white colorant some people choose to avoid. 94 of 262 checked products list titanium dioxide; 168 do not.
Does not list titanium dioxide
- A-S Medication Solutions: 750 mg extended-release tablet (NDC 50090-7378-00), 750 mg extended-release tablet (NDC 50090-7379-00), 750 mg extended-release tablet (NDC 50090-7748-00), 1500 mg extended-release tablet (NDC 50090-5665-00), 1500 mg extended-release tablet (NDC 50090-6253-00), 1500 mg extended-release tablet (NDC 50090-6866-00), 1500 mg extended-release tablet (NDC 50090-6867-00), 1500 mg extended-release tablet (NDC 50090-7192-00), 1500 mg extended-release tablet (NDC 50090-7193-00), 1500 mg extended-release tablet (NDC 50090-7456-00), 1500 mg extended-release tablet (NDC 50090-7616-00)
- Actavis: 20 mEq extended-release tablet
- Advagen Pharma Limited: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Advagen Pharma Ltd.: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Ajenat: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- American Health Packaging: 20 mEq extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution (NDC 60687-0628-07), 1.5 g/15 mL oral solution (NDC 60687-0884-07)
- Amneal Pharmaceuticals LLC: 1.5 g/1.58 g oral solution
- Amneal Pharmaceuticals NY LLC: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- ANI: 1.5 g/1.56 g oral solution
- Aphena Pharma Solutions - Tennessee: 1500 mg extended-release tablet
- Atlantic Biologicals: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Aurobindo: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- AvKARE: 1500 mg extended-release tablet
- AvPAK: 3 g/15 mL oral solution
- B. Braun Medical: 14.9 g/100 mL injection
- Baxter Healthcare: 7.46 g/1000 mL injection, 14.9 g/1000 mL injection, 29.8 g/1000 mL injection
- Bluepoint: 750 mg tablet, 1500 mg tablet
- BPI: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Bryant Ranch Prepack: 750 mg extended-release tablet (NDC 63629-1072-01), 750 mg extended-release tablet (NDC 63629-1073-01), 750 mg extended-release tablet (NDC 63629-1074-01), 750 mg extended-release tablet (NDC 63629-1075-01), 750 mg extended-release tablet (NDC 71335-1900-01), 750 mg extended-release tablet (NDC 71335-2503-01), 750 mg extended-release tablet (NDC 71335-2607-01), 750 mg extended-release tablet (NDC 71335-2866-01), 750 mg extended-release tablet (NDC 71335-2913-01), 750 mg extended-release tablet (NDC 71335-2958-01), 750 mg extended-release tablet (NDC 72162-1786-00), 1500 mg extended-release tablet (NDC 71335-1896-01), 1500 mg extended-release tablet (NDC 71335-1109-01), 1500 mg extended-release tablet (NDC 71335-1747-01), 1500 mg extended-release tablet (NDC 71335-2045-01), 1.5 g/1.77 g oral solution
- Camber: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Cardinal Health 107: 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution
- Carwin Pharmaceutical Associates: 0.75 g/0.79 g oral solution, 1.125 g/1.185 g oral solution, 10 mEq/15 mL oral solution
- Direct_Rx: 750 mg extended-release tablet, 1500 mg extended-release tablet
- Endo: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Epic: 1.5 g/1.77 g oral solution
- Fresenius Kabi: 2 mEq/mL injection (NDC 63323-0965-05), 2 mEq/mL injection (NDC 63323-0967-30), 10 mEq/50 mL injection, 10 mEq/100 mL injection, 20 mEq/50 mL injection, 20 mEq/100 mL injection, 40 mEq/100 mL injection
- Genus Lifesciences: 20 mEq/15 mL oral solution
- Genus Lifesciences Inc.: 1.5 g/1.58 g oral solution
- Granules India: 750 mg tablet, 1500 mg tablet
- Granules Pharmaceuticals Inc.: 750 mg extended-release tablet, 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Guardian Drug: 1.5 g/1.57 g oral solution
- Henry Schein: 2 mEq/mL injection, 149 mg/mL injection
- Heritage Pharmaceuticals Inc. d/b/a Avet: 1.5 g/1.58 g oral solution
- HF Acquisition Co LLC, DBA HealthFirst: 149 mg/mL injection (NDC 51662-1421-01), 149 mg/mL injection (NDC 51662-1387-01)
- Hospira: 149 mg/mL injection (NDC 00409-6635-01), 149 mg/mL injection (NDC 00409-6651-06)
- ICU Medical: 10 mEq/100 mL injection, 200 mEq/1000 mL injection, 400 mEq/1000 mL injection
- IPG: 3 g/3.16 g oral solution
- Kesin: 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution, 3 g/30 mL oral solution
- Lupin Pharmaceuticals,Inc.: 10 mEq extended-release tablet, 20 mEq extended-release tablet, 1.5 g/1.54 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Macleods: 20 mEq/15 mL oral solution
- Major: 20 mEq extended-release tablet, 750 mg extended-release tablet, 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/30 mL oral solution
- Marlex Pharmaceuticals, Inc.: 1.5 g/1.58 g oral solution
- Marlex Pharmaceuticals Inc: 1.5 g/1.58 g oral solution, 3 g/4.75 g oral solution
- NCS HealthCare of KY, LLC dba Vangard: 750 mg extended-release tablet, 1500 mg extended-release tablet
- Northstar Rx: 750 mg extended-release tablet, 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Northwind Health: 750 mg extended-release tablet, 1500 mg extended-release tablet
- Novel: 1.5 g/1.54 g oral solution
- PAI Holdings, LLC dba PAI: 20 mEq/15 mL oral solution (NDC 00121-0948-16), 20 mEq/15 mL oral solution (NDC 00121-4948-00), 20 mEq/30 mL oral solution, 40 mEq/15 mL oral solution
- PD-Rx: 20 mEq extended-release tablet
- Preferred: 1500 mg extended-release tablet
- Proficient Rx: 750 mg extended-release tablet, 1500 mg extended-release tablet
- Redpharm Drug: 1500 mg extended-release tablet (NDC 67296-2131-02), 1500 mg extended-release tablet (NDC 67296-2160-01), 1500 mg extended-release tablet (NDC 67296-2243-06)
- Remedyrepack: 750 mg extended-release tablet (NDC 70518-3024-01), 750 mg extended-release tablet (NDC 70518-4095-02), 1500 mg extended-release tablet
- Saptalis: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Solco Healthcare: 750 mg tablet, 1125 mg tablet
- Somerset Therapeutics: 1.5 g/1.58 g oral solution
- Strides Pharma Science: 1.5 g/1.58 g oral solution
- Sun: 20 mEq extended-release tablet, 750 mg extended-release tablet
- Tris: 20 mEq/15 mL oral solution
- Upsher-Smith: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet, 1.5 g oral solution
- Upsher-SmithLaboratories: 750 mg extended-release tablet, 1500 mg extended-release tablet
- XLCare: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus: 750 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus Lifesciences: 750 mg extended-release tablet
Lists titanium dioxide
- A-S Medication Solutions: 10 mEq extended-release capsule, 750 mg extended-release capsule, 10 mEq extended-release tablet, 750 mg extended-release tablet (NDC 50090-6639-00), 750 mg extended-release tablet (NDC 50090-6640-00), 750 mg extended-release tablet (NDC 50090-5335-00), 750 mg extended-release tablet (NDC 50090-7639-00), 750 mg extended-release tablet (NDC 50090-7640-00), 750 mg extended-release tablet (NDC 50090-7749-00)
- Actavis: 750 mg extended-release capsule
- Adare: 600 mg capsule, 750 mg capsule
- Advagen Pharma Ltd: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- American Health Packaging: 750 mg extended-release capsule
- Amneal Pharmaceuticals of New York: 750 mg extended-release capsule
- Aphena Pharma Solutions - Tennessee: 750 mg extended-release tablet (NDC 71610-0977-30), 750 mg extended-release tablet (NDC 71610-0935-60), 750 mg extended-release tablet (NDC 71610-0932-60), 750 mg extended-release tablet (NDC 71610-0960-60), 750 mg extended-release tablet (NDC 71610-0945-30), 750 mg extended-release tablet (NDC 71610-0944-30), 750 mg extended-release tablet (NDC 71610-0349-15)
- Aurobindo: 600 mg extended-release tablet, 750 mg extended-release tablet
- AvKARE: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 42291-0487-01), 750 mg extended-release tablet (NDC 42291-0506-01)
- AvPAK: 750 mg extended-release capsule
- BluePoint: 750 mg extended-release capsule (NDC 68001-0396-00), 750 mg extended-release capsule (NDC 68001-0619-00), 750 mg extended-release tablet
- Bryant Ranch Prepack: 600 mg extended-release capsule, 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 71335-1131-01), 750 mg extended-release tablet (NDC 71335-2447-01)
- Coupler: 750 mg extended-release tablet
- Direct_Rx: 750 mg extended-release tablet
- Epic: 600 mg extended-release tablet, 750 mg extended-release tablet
- Glenmark: 750 mg extended-release capsule
- Granules India: 600 mg extended-release capsule, 750 mg extended-release capsule
- Granules Pharmaceuticals Inc: 600 mg extended-release capsule, 750 mg extended-release capsule
- Granules Pharmaceuticals Inc.: 600 mg extended-release tablet, 750 mg extended-release tablet
- Lupin Pharmaceuticals, Inc.: 10 mEq extended-release capsule
- Macleods: 750 mg extended-release tablet
- Major: 750 mg extended-release capsule, 750 mg extended-release tablet
- Mylan: 8 mEq extended-release tablet, 10 mEq extended-release tablet
- NCS HealthCare of KY, LLC dba Vangard: 750 mg extended-release capsule, 750 mg extended-release tablet
- Northstar Rx: 750 mg extended-release capsule
- Northwind Health: 750 mg extended-release tablet (NDC 82868-0111-90), 750 mg extended-release tablet (NDC 51655-0706-52), 750 mg extended-release tablet (NDC 51655-0226-26), 750 mg extended-release tablet (NDC 51655-0463-84)
- PD-Rx: 600 mg extended-release capsule, 750 mg extended-release capsule, 750 mg extended-release tablet, 1500 mg extended-release tablet
- Proficient Rx: 750 mg extended-release tablet, 1500 mg extended-release tablet
- Remedyrepack: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 70518-4520-00), 750 mg extended-release tablet (NDC 70518-2964-00)
- Rising: 600 mg extended-release tablet, 750 mg extended-release tablet
- Slate Run: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 70436-0002-01), 750 mg extended-release tablet (NDC 70436-0152-01)
- Solco Healthcare: 600 mg extended-release capsule, 750 mg extended-release capsule
- St. Mary's Medical Park Pharmacy: 750 mg extended-release tablet
- Strides Pharma Science: 600 mg extended-release tablet, 750 mg extended-release tablet
- Sun: 600 mg extended-release capsule, 750 mg extended-release capsule
- Upsher-Smith: 600 mg extended-release tablet (NDC 24979-0229-00), 600 mg extended-release tablet (NDC 00245-0835-11), 600 mg extended-release tablet (NDC 00245-5315-01), 600 mg extended-release tablet (NDC 00832-5322-10), 750 mg extended-release tablet (NDC 24979-0231-01), 750 mg extended-release tablet (NDC 24979-0230-00), 750 mg extended-release tablet (NDC 00245-0836-11), 750 mg extended-release tablet (NDC 00245-5316-01), 750 mg extended-release tablet (NDC 00832-5323-10), 1500 mg extended-release tablet
- Zydus: 600 mg extended-release capsule, 750 mg extended-release capsule
Potassium Chloride without carmine or shellac
Carmine or shellac: insect-derived red colorant or coating glaze. 16 of 262 checked products list carmine or shellac; 246 do not.
Does not list carmine or shellac
- A-S Medication Solutions: 10 mEq extended-release tablet, 750 mg extended-release tablet (NDC 50090-6639-00), 750 mg extended-release tablet (NDC 50090-6640-00), 750 mg extended-release tablet (NDC 50090-5335-00), 750 mg extended-release tablet (NDC 50090-7378-00), 750 mg extended-release tablet (NDC 50090-7379-00), 750 mg extended-release tablet (NDC 50090-7639-00), 750 mg extended-release tablet (NDC 50090-7640-00), 750 mg extended-release tablet (NDC 50090-7748-00), 750 mg extended-release tablet (NDC 50090-7749-00), 1500 mg extended-release tablet (NDC 50090-5665-00), 1500 mg extended-release tablet (NDC 50090-6253-00), 1500 mg extended-release tablet (NDC 50090-6866-00), 1500 mg extended-release tablet (NDC 50090-6867-00), 1500 mg extended-release tablet (NDC 50090-7192-00), 1500 mg extended-release tablet (NDC 50090-7193-00), 1500 mg extended-release tablet (NDC 50090-7456-00), 1500 mg extended-release tablet (NDC 50090-7616-00)
- Actavis: 750 mg extended-release capsule, 20 mEq extended-release tablet
- Adare: 600 mg capsule, 750 mg capsule
- Advagen Pharma Limited: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Advagen Pharma Ltd: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Advagen Pharma Ltd.: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Ajenat: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- American Health Packaging: 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution (NDC 60687-0628-07), 1.5 g/15 mL oral solution (NDC 60687-0884-07)
- Amneal Pharmaceuticals LLC: 1.5 g/1.58 g oral solution
- Amneal Pharmaceuticals NY LLC: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Amneal Pharmaceuticals of New York: 750 mg extended-release capsule
- ANI: 1.5 g/1.56 g oral solution
- Aphena Pharma Solutions - Tennessee: 750 mg extended-release tablet (NDC 71610-0977-30), 750 mg extended-release tablet (NDC 71610-0935-60), 750 mg extended-release tablet (NDC 71610-0932-60), 750 mg extended-release tablet (NDC 71610-0960-60), 750 mg extended-release tablet (NDC 71610-0945-30), 750 mg extended-release tablet (NDC 71610-0944-30), 750 mg extended-release tablet (NDC 71610-0349-15), 1500 mg extended-release tablet
- Atlantic Biologicals: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Aurobindo: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 59651-0429-01), 750 mg extended-release tablet (NDC 65862-0987-01), 1125 mg extended-release tablet, 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- AvKARE: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 42291-0487-01), 750 mg extended-release tablet (NDC 42291-0506-01), 1500 mg extended-release tablet
- AvPAK: 750 mg extended-release capsule, 3 g/15 mL oral solution
- B. Braun Medical: 14.9 g/100 mL injection
- Baxter Healthcare: 7.46 g/1000 mL injection, 14.9 g/1000 mL injection, 29.8 g/1000 mL injection
- BluePoint: 750 mg extended-release tablet
- Bluepoint: 750 mg tablet, 1500 mg tablet
- BPI: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Bryant Ranch Prepack: 600 mg extended-release capsule, 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 63629-1072-01), 750 mg extended-release tablet (NDC 63629-1073-01), 750 mg extended-release tablet (NDC 63629-1074-01), 750 mg extended-release tablet (NDC 63629-1075-01), 750 mg extended-release tablet (NDC 71335-1131-01), 750 mg extended-release tablet (NDC 71335-1900-01), 750 mg extended-release tablet (NDC 71335-2447-01), 750 mg extended-release tablet (NDC 71335-2503-01), 750 mg extended-release tablet (NDC 71335-2607-01), 750 mg extended-release tablet (NDC 71335-2866-01), 750 mg extended-release tablet (NDC 71335-2913-01), 750 mg extended-release tablet (NDC 71335-2958-01), 750 mg extended-release tablet (NDC 72162-1786-00), 1500 mg extended-release tablet (NDC 71335-1896-01), 1500 mg extended-release tablet (NDC 71335-1109-01), 1500 mg extended-release tablet (NDC 71335-1747-01), 1500 mg extended-release tablet (NDC 71335-2045-01), 1.5 g/1.77 g oral solution
- Camber: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Cardinal Health 107: 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution
- Carwin Pharmaceutical Associates: 0.75 g/0.79 g oral solution, 1.125 g/1.185 g oral solution, 10 mEq/15 mL oral solution
- Coupler: 750 mg extended-release tablet
- Direct_Rx: 750 mg extended-release tablet (NDC 72189-0648-04), 750 mg extended-release tablet (NDC 72189-0027-04), 1500 mg extended-release tablet
- Endo: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Epic: 600 mg extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.77 g oral solution
- Fresenius Kabi: 2 mEq/mL injection (NDC 63323-0965-05), 2 mEq/mL injection (NDC 63323-0967-30), 10 mEq/50 mL injection, 10 mEq/100 mL injection, 20 mEq/50 mL injection, 20 mEq/100 mL injection, 40 mEq/100 mL injection
- Genus Lifesciences: 20 mEq/15 mL oral solution
- Genus Lifesciences Inc.: 1.5 g/1.58 g oral solution
- Granules India: 750 mg tablet, 1500 mg tablet
- Granules Pharmaceuticals Inc.: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 70010-0136-01), 750 mg extended-release tablet (NDC 70010-0022-01), 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Guardian Drug: 1.5 g/1.57 g oral solution
- Henry Schein: 2 mEq/mL injection, 149 mg/mL injection
- Heritage Pharmaceuticals Inc. d/b/a Avet: 1.5 g/1.58 g oral solution
- HF Acquisition Co LLC, DBA HealthFirst: 149 mg/mL injection (NDC 51662-1421-01), 149 mg/mL injection (NDC 51662-1387-01)
- Hospira: 149 mg/mL injection (NDC 00409-6635-01), 149 mg/mL injection (NDC 00409-6651-06)
- ICU Medical: 10 mEq/100 mL injection, 200 mEq/1000 mL injection, 400 mEq/1000 mL injection
- IPG: 3 g/3.16 g oral solution
- Kesin: 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution, 3 g/30 mL oral solution
- Lupin Pharmaceuticals,Inc.: 10 mEq extended-release tablet, 20 mEq extended-release tablet, 1.5 g/1.54 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Macleods: 750 mg extended-release tablet, 20 mEq/15 mL oral solution
- Major: 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet (NDC 00904-7547-61), 750 mg extended-release tablet (NDC 00904-7216-61), 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/30 mL oral solution
- Marlex Pharmaceuticals, Inc.: 1.5 g/1.58 g oral solution
- Marlex Pharmaceuticals Inc: 1.5 g/1.58 g oral solution, 3 g/4.75 g oral solution
- Mylan: 8 mEq extended-release tablet, 10 mEq extended-release tablet
- NCS HealthCare of KY, LLC dba Vangard: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 00615-8399-05), 750 mg extended-release tablet (NDC 00615-8570-05), 1500 mg extended-release tablet
- Northstar Rx: 750 mg extended-release tablet, 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Northwind Health: 750 mg extended-release tablet (NDC 82868-0027-90), 750 mg extended-release tablet (NDC 82868-0111-90), 750 mg extended-release tablet (NDC 51655-0706-52), 750 mg extended-release tablet (NDC 51655-0226-26), 750 mg extended-release tablet (NDC 51655-0463-84), 1500 mg extended-release tablet
- Novel: 1.5 g/1.54 g oral solution
- PAI Holdings, LLC dba PAI: 20 mEq/15 mL oral solution (NDC 00121-0948-16), 20 mEq/15 mL oral solution (NDC 00121-4948-00), 20 mEq/30 mL oral solution, 40 mEq/15 mL oral solution
- PD-Rx: 600 mg extended-release capsule, 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet, 1500 mg extended-release tablet
- Preferred: 1500 mg extended-release tablet
- Proficient Rx: 750 mg extended-release tablet (NDC 82804-0109-30), 750 mg extended-release tablet (NDC 82804-0187-30), 1500 mg extended-release tablet (NDC 71205-0824-03), 1500 mg extended-release tablet (NDC 82804-0057-30)
- Redpharm Drug: 1500 mg extended-release tablet (NDC 67296-2131-02), 1500 mg extended-release tablet (NDC 67296-2160-01), 1500 mg extended-release tablet (NDC 67296-2243-06)
- Remedyrepack: 750 mg extended-release tablet (NDC 70518-3024-01), 750 mg extended-release tablet (NDC 70518-4095-02), 750 mg extended-release tablet (NDC 70518-4520-00), 750 mg extended-release tablet (NDC 70518-2964-00), 1500 mg extended-release tablet
- Rising: 600 mg extended-release tablet, 750 mg extended-release tablet
- Saptalis: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Slate Run: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 70436-0002-01), 750 mg extended-release tablet (NDC 70436-0152-01)
- Solco Healthcare: 750 mg tablet, 1125 mg tablet
- Somerset Therapeutics: 1.5 g/1.58 g oral solution
- St. Mary's Medical Park Pharmacy: 750 mg extended-release tablet
- Strides Pharma Science: 600 mg extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Sun: 600 mg extended-release capsule, 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet
- Tris: 20 mEq/15 mL oral solution
- Upsher-Smith: 600 mg extended-release tablet (NDC 24979-0229-00), 600 mg extended-release tablet (NDC 00245-0835-11), 600 mg extended-release tablet (NDC 00245-5315-01), 600 mg extended-release tablet (NDC 00832-5322-10), 750 mg extended-release tablet (NDC 24979-0231-01), 750 mg extended-release tablet (NDC 24979-0230-00), 750 mg extended-release tablet (NDC 00245-5317-01), 750 mg extended-release tablet (NDC 00245-0836-11), 750 mg extended-release tablet (NDC 00245-5316-01), 750 mg extended-release tablet (NDC 00832-5323-10), 1125 mg extended-release tablet, 1500 mg extended-release tablet (NDC 24979-0232-01), 1500 mg extended-release tablet (NDC 00245-5319-01), 1.5 g oral solution
- Upsher-SmithLaboratories: 750 mg extended-release tablet, 1500 mg extended-release tablet
- XLCare: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus: 750 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus Lifesciences: 750 mg extended-release tablet
Lists carmine or shellac
- A-S Medication Solutions: 10 mEq extended-release capsule, 750 mg extended-release capsule
- BluePoint: 750 mg extended-release capsule (NDC 68001-0396-00), 750 mg extended-release capsule (NDC 68001-0619-00)
- Glenmark: 750 mg extended-release capsule
- Granules India: 600 mg extended-release capsule, 750 mg extended-release capsule
- Granules Pharmaceuticals Inc: 600 mg extended-release capsule, 750 mg extended-release capsule
- Lupin Pharmaceuticals, Inc.: 10 mEq extended-release capsule
- Northstar Rx: 750 mg extended-release capsule
- Remedyrepack: 750 mg extended-release capsule
- Solco Healthcare: 600 mg extended-release capsule, 750 mg extended-release capsule
- Zydus: 600 mg extended-release capsule, 750 mg extended-release capsule
Potassium Chloride without alcohol (ethanol)
Alcohol (ethanol): mostly in liquids; a concern in alcohol recovery, for children, or with disulfiram or metronidazole. 2 of 262 checked products list alcohol (ethanol); 260 do not.
Does not list alcohol (ethanol)
- A-S Medication Solutions: 10 mEq extended-release capsule, 750 mg extended-release capsule, 10 mEq extended-release tablet, 750 mg extended-release tablet (NDC 50090-6639-00), 750 mg extended-release tablet (NDC 50090-6640-00), 750 mg extended-release tablet (NDC 50090-5335-00), 750 mg extended-release tablet (NDC 50090-7378-00), 750 mg extended-release tablet (NDC 50090-7379-00), 750 mg extended-release tablet (NDC 50090-7639-00), 750 mg extended-release tablet (NDC 50090-7640-00), 750 mg extended-release tablet (NDC 50090-7748-00), 750 mg extended-release tablet (NDC 50090-7749-00), 1500 mg extended-release tablet (NDC 50090-5665-00), 1500 mg extended-release tablet (NDC 50090-6253-00), 1500 mg extended-release tablet (NDC 50090-6866-00), 1500 mg extended-release tablet (NDC 50090-6867-00), 1500 mg extended-release tablet (NDC 50090-7192-00), 1500 mg extended-release tablet (NDC 50090-7193-00), 1500 mg extended-release tablet (NDC 50090-7456-00), 1500 mg extended-release tablet (NDC 50090-7616-00)
- Actavis: 750 mg extended-release capsule, 20 mEq extended-release tablet
- Adare: 600 mg capsule, 750 mg capsule
- Advagen Pharma Limited: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Advagen Pharma Ltd: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Advagen Pharma Ltd.: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Ajenat: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- American Health Packaging: 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution (NDC 60687-0628-07), 1.5 g/15 mL oral solution (NDC 60687-0884-07)
- Amneal Pharmaceuticals LLC: 1.5 g/1.58 g oral solution
- Amneal Pharmaceuticals NY LLC: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Amneal Pharmaceuticals of New York: 750 mg extended-release capsule
- ANI: 1.5 g/1.56 g oral solution
- Aphena Pharma Solutions - Tennessee: 750 mg extended-release tablet (NDC 71610-0977-30), 750 mg extended-release tablet (NDC 71610-0935-60), 750 mg extended-release tablet (NDC 71610-0932-60), 750 mg extended-release tablet (NDC 71610-0960-60), 750 mg extended-release tablet (NDC 71610-0945-30), 750 mg extended-release tablet (NDC 71610-0944-30), 750 mg extended-release tablet (NDC 71610-0349-15), 1500 mg extended-release tablet
- Atlantic Biologicals: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Aurobindo: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 59651-0429-01), 750 mg extended-release tablet (NDC 65862-0987-01), 1125 mg extended-release tablet, 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- AvKARE: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 42291-0487-01), 750 mg extended-release tablet (NDC 42291-0506-01), 1500 mg extended-release tablet
- AvPAK: 750 mg extended-release capsule, 3 g/15 mL oral solution
- B. Braun Medical: 14.9 g/100 mL injection
- Baxter Healthcare: 7.46 g/1000 mL injection, 14.9 g/1000 mL injection, 29.8 g/1000 mL injection
- BluePoint: 750 mg extended-release capsule (NDC 68001-0396-00), 750 mg extended-release capsule (NDC 68001-0619-00), 750 mg extended-release tablet
- Bluepoint: 750 mg tablet, 1500 mg tablet
- BPI: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Bryant Ranch Prepack: 600 mg extended-release capsule, 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 63629-1072-01), 750 mg extended-release tablet (NDC 63629-1073-01), 750 mg extended-release tablet (NDC 63629-1074-01), 750 mg extended-release tablet (NDC 63629-1075-01), 750 mg extended-release tablet (NDC 71335-1131-01), 750 mg extended-release tablet (NDC 71335-1900-01), 750 mg extended-release tablet (NDC 71335-2447-01), 750 mg extended-release tablet (NDC 71335-2503-01), 750 mg extended-release tablet (NDC 71335-2607-01), 750 mg extended-release tablet (NDC 71335-2866-01), 750 mg extended-release tablet (NDC 71335-2913-01), 750 mg extended-release tablet (NDC 71335-2958-01), 750 mg extended-release tablet (NDC 72162-1786-00), 1500 mg extended-release tablet (NDC 71335-1896-01), 1500 mg extended-release tablet (NDC 71335-1109-01), 1500 mg extended-release tablet (NDC 71335-1747-01), 1500 mg extended-release tablet (NDC 71335-2045-01), 1.5 g/1.77 g oral solution
- Camber: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Cardinal Health 107: 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution
- Carwin Pharmaceutical Associates: 0.75 g/0.79 g oral solution, 1.125 g/1.185 g oral solution, 10 mEq/15 mL oral solution
- Coupler: 750 mg extended-release tablet
- Direct_Rx: 750 mg extended-release tablet (NDC 72189-0648-04), 750 mg extended-release tablet (NDC 72189-0027-04), 1500 mg extended-release tablet
- Endo: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Epic: 600 mg extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.77 g oral solution
- Fresenius Kabi: 2 mEq/mL injection (NDC 63323-0965-05), 2 mEq/mL injection (NDC 63323-0967-30), 10 mEq/50 mL injection, 10 mEq/100 mL injection, 20 mEq/50 mL injection, 20 mEq/100 mL injection, 40 mEq/100 mL injection
- Genus Lifesciences: 20 mEq/15 mL oral solution
- Genus Lifesciences Inc.: 1.5 g/1.58 g oral solution
- Glenmark: 750 mg extended-release capsule
- Granules India: 600 mg extended-release capsule, 750 mg extended-release capsule, 750 mg tablet, 1500 mg tablet
- Granules Pharmaceuticals Inc: 600 mg extended-release capsule, 750 mg extended-release capsule
- Granules Pharmaceuticals Inc.: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 70010-0136-01), 750 mg extended-release tablet (NDC 70010-0022-01), 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Guardian Drug: 1.5 g/1.57 g oral solution
- Henry Schein: 2 mEq/mL injection, 149 mg/mL injection
- Heritage Pharmaceuticals Inc. d/b/a Avet: 1.5 g/1.58 g oral solution
- HF Acquisition Co LLC, DBA HealthFirst: 149 mg/mL injection (NDC 51662-1421-01), 149 mg/mL injection (NDC 51662-1387-01)
- Hospira: 149 mg/mL injection (NDC 00409-6635-01), 149 mg/mL injection (NDC 00409-6651-06)
- ICU Medical: 10 mEq/100 mL injection, 200 mEq/1000 mL injection, 400 mEq/1000 mL injection
- IPG: 3 g/3.16 g oral solution
- Kesin: 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution, 3 g/30 mL oral solution
- Lupin Pharmaceuticals, Inc.: 10 mEq extended-release capsule
- Lupin Pharmaceuticals,Inc.: 1.5 g/1.54 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Macleods: 750 mg extended-release tablet, 20 mEq/15 mL oral solution
- Major: 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet (NDC 00904-7547-61), 750 mg extended-release tablet (NDC 00904-7216-61), 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/30 mL oral solution
- Marlex Pharmaceuticals, Inc.: 1.5 g/1.58 g oral solution
- Marlex Pharmaceuticals Inc: 1.5 g/1.58 g oral solution, 3 g/4.75 g oral solution
- Mylan: 8 mEq extended-release tablet, 10 mEq extended-release tablet
- NCS HealthCare of KY, LLC dba Vangard: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 00615-8399-05), 750 mg extended-release tablet (NDC 00615-8570-05), 1500 mg extended-release tablet
- Northstar Rx: 750 mg extended-release capsule, 750 mg extended-release tablet, 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Northwind Health: 750 mg extended-release tablet (NDC 82868-0027-90), 750 mg extended-release tablet (NDC 82868-0111-90), 750 mg extended-release tablet (NDC 51655-0706-52), 750 mg extended-release tablet (NDC 51655-0226-26), 750 mg extended-release tablet (NDC 51655-0463-84), 1500 mg extended-release tablet
- Novel: 1.5 g/1.54 g oral solution
- PAI Holdings, LLC dba PAI: 20 mEq/15 mL oral solution (NDC 00121-0948-16), 20 mEq/15 mL oral solution (NDC 00121-4948-00), 20 mEq/30 mL oral solution, 40 mEq/15 mL oral solution
- PD-Rx: 600 mg extended-release capsule, 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet, 1500 mg extended-release tablet
- Preferred: 1500 mg extended-release tablet
- Proficient Rx: 750 mg extended-release tablet (NDC 82804-0109-30), 750 mg extended-release tablet (NDC 82804-0187-30), 1500 mg extended-release tablet (NDC 71205-0824-03), 1500 mg extended-release tablet (NDC 82804-0057-30)
- Redpharm Drug: 1500 mg extended-release tablet (NDC 67296-2131-02), 1500 mg extended-release tablet (NDC 67296-2160-01), 1500 mg extended-release tablet (NDC 67296-2243-06)
- Remedyrepack: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 70518-3024-01), 750 mg extended-release tablet (NDC 70518-4095-02), 750 mg extended-release tablet (NDC 70518-4520-00), 750 mg extended-release tablet (NDC 70518-2964-00), 1500 mg extended-release tablet
- Rising: 600 mg extended-release tablet, 750 mg extended-release tablet
- Saptalis: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Slate Run: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 70436-0002-01), 750 mg extended-release tablet (NDC 70436-0152-01)
- Solco Healthcare: 600 mg extended-release capsule, 750 mg extended-release capsule, 750 mg tablet, 1125 mg tablet
- Somerset Therapeutics: 1.5 g/1.58 g oral solution
- St. Mary's Medical Park Pharmacy: 750 mg extended-release tablet
- Strides Pharma Science: 600 mg extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Sun: 600 mg extended-release capsule, 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet
- Tris: 20 mEq/15 mL oral solution
- Upsher-Smith: 600 mg extended-release tablet (NDC 24979-0229-00), 600 mg extended-release tablet (NDC 00245-0835-11), 600 mg extended-release tablet (NDC 00245-5315-01), 600 mg extended-release tablet (NDC 00832-5322-10), 750 mg extended-release tablet (NDC 24979-0231-01), 750 mg extended-release tablet (NDC 24979-0230-00), 750 mg extended-release tablet (NDC 00245-5317-01), 750 mg extended-release tablet (NDC 00245-0836-11), 750 mg extended-release tablet (NDC 00245-5316-01), 750 mg extended-release tablet (NDC 00832-5323-10), 1125 mg extended-release tablet, 1500 mg extended-release tablet (NDC 24979-0232-01), 1500 mg extended-release tablet (NDC 00245-5319-01), 1.5 g oral solution
- Upsher-SmithLaboratories: 750 mg extended-release tablet, 1500 mg extended-release tablet
- XLCare: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus: 600 mg extended-release capsule, 750 mg extended-release capsule, 750 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus Lifesciences: 750 mg extended-release tablet
Lists alcohol (ethanol)
- Lupin Pharmaceuticals,Inc.: 10 mEq extended-release tablet, 20 mEq extended-release tablet
Potassium Chloride without propylene glycol
Propylene glycol: A solvent in liquids and capsules; a concern in kidney disease, for infants, and at high doses. 43 of 262 checked products list propylene glycol; 219 do not.
Does not list propylene glycol
- A-S Medication Solutions: 10 mEq extended-release tablet, 750 mg extended-release tablet (NDC 50090-6639-00), 750 mg extended-release tablet (NDC 50090-6640-00), 750 mg extended-release tablet (NDC 50090-5335-00), 750 mg extended-release tablet (NDC 50090-7378-00), 750 mg extended-release tablet (NDC 50090-7379-00), 750 mg extended-release tablet (NDC 50090-7639-00), 750 mg extended-release tablet (NDC 50090-7640-00), 750 mg extended-release tablet (NDC 50090-7748-00), 750 mg extended-release tablet (NDC 50090-7749-00), 1500 mg extended-release tablet (NDC 50090-5665-00), 1500 mg extended-release tablet (NDC 50090-6253-00), 1500 mg extended-release tablet (NDC 50090-6866-00), 1500 mg extended-release tablet (NDC 50090-6867-00), 1500 mg extended-release tablet (NDC 50090-7192-00), 1500 mg extended-release tablet (NDC 50090-7193-00), 1500 mg extended-release tablet (NDC 50090-7456-00), 1500 mg extended-release tablet (NDC 50090-7616-00)
- Actavis: 750 mg extended-release capsule, 20 mEq extended-release tablet
- Adare: 600 mg capsule, 750 mg capsule
- Advagen Pharma Limited: 1.5 g/1.58 g oral solution
- Advagen Pharma Ltd: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Advagen Pharma Ltd.: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Ajenat: 1.5 g/1.58 g oral solution
- American Health Packaging: 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Amneal Pharmaceuticals LLC: 1.5 g/1.58 g oral solution
- Amneal Pharmaceuticals of New York: 750 mg extended-release capsule
- ANI: 1.5 g/1.56 g oral solution
- Aphena Pharma Solutions - Tennessee: 750 mg extended-release tablet (NDC 71610-0977-30), 750 mg extended-release tablet (NDC 71610-0935-60), 750 mg extended-release tablet (NDC 71610-0932-60), 750 mg extended-release tablet (NDC 71610-0960-60), 750 mg extended-release tablet (NDC 71610-0945-30), 750 mg extended-release tablet (NDC 71610-0944-30), 750 mg extended-release tablet (NDC 71610-0349-15), 1500 mg extended-release tablet
- Aurobindo: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 59651-0429-01), 750 mg extended-release tablet (NDC 65862-0987-01), 1125 mg extended-release tablet, 1500 mg extended-release tablet
- AvKARE: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 42291-0487-01), 750 mg extended-release tablet (NDC 42291-0506-01), 1500 mg extended-release tablet
- AvPAK: 750 mg extended-release capsule
- B. Braun Medical: 14.9 g/100 mL injection
- Baxter Healthcare: 7.46 g/1000 mL injection, 14.9 g/1000 mL injection, 29.8 g/1000 mL injection
- BluePoint: 750 mg extended-release capsule, 750 mg extended-release tablet
- Bluepoint: 750 mg tablet, 1500 mg tablet
- BPI: 1.5 g/1.58 g oral solution
- Bryant Ranch Prepack: 600 mg extended-release capsule, 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 63629-1072-01), 750 mg extended-release tablet (NDC 63629-1073-01), 750 mg extended-release tablet (NDC 63629-1074-01), 750 mg extended-release tablet (NDC 63629-1075-01), 750 mg extended-release tablet (NDC 71335-1131-01), 750 mg extended-release tablet (NDC 71335-1900-01), 750 mg extended-release tablet (NDC 71335-2447-01), 750 mg extended-release tablet (NDC 71335-2503-01), 750 mg extended-release tablet (NDC 71335-2607-01), 750 mg extended-release tablet (NDC 71335-2866-01), 750 mg extended-release tablet (NDC 71335-2913-01), 750 mg extended-release tablet (NDC 71335-2958-01), 750 mg extended-release tablet (NDC 72162-1786-00), 1500 mg extended-release tablet (NDC 71335-1896-01), 1500 mg extended-release tablet (NDC 71335-1109-01), 1500 mg extended-release tablet (NDC 71335-1747-01), 1500 mg extended-release tablet (NDC 71335-2045-01), 1.5 g/1.77 g oral solution
- Camber: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Cardinal Health 107: 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Carwin Pharmaceutical Associates: 0.75 g/0.79 g oral solution, 1.125 g/1.185 g oral solution, 10 mEq/15 mL oral solution
- Coupler: 750 mg extended-release tablet
- Direct_Rx: 750 mg extended-release tablet (NDC 72189-0648-04), 750 mg extended-release tablet (NDC 72189-0027-04), 1500 mg extended-release tablet
- Endo: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Epic: 600 mg extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.77 g oral solution
- Fresenius Kabi: 2 mEq/mL injection (NDC 63323-0965-05), 2 mEq/mL injection (NDC 63323-0967-30), 10 mEq/50 mL injection, 10 mEq/100 mL injection, 20 mEq/50 mL injection, 20 mEq/100 mL injection, 40 mEq/100 mL injection
- Genus Lifesciences: 20 mEq/15 mL oral solution
- Genus Lifesciences Inc.: 1.5 g/1.58 g oral solution
- Glenmark: 750 mg extended-release capsule
- Granules India: 750 mg tablet, 1500 mg tablet
- Granules Pharmaceuticals Inc.: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 70010-0136-01), 750 mg extended-release tablet (NDC 70010-0022-01), 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Guardian Drug: 1.5 g/1.57 g oral solution
- Henry Schein: 2 mEq/mL injection, 149 mg/mL injection
- Heritage Pharmaceuticals Inc. d/b/a Avet: 1.5 g/1.58 g oral solution
- HF Acquisition Co LLC, DBA HealthFirst: 149 mg/mL injection (NDC 51662-1421-01), 149 mg/mL injection (NDC 51662-1387-01)
- Hospira: 149 mg/mL injection (NDC 00409-6635-01), 149 mg/mL injection (NDC 00409-6651-06)
- ICU Medical: 10 mEq/100 mL injection, 200 mEq/1000 mL injection, 400 mEq/1000 mL injection
- IPG: 3 g/3.16 g oral solution
- Kesin: 1.5 g/1.58 g oral solution
- Lupin Pharmaceuticals,Inc.: 10 mEq extended-release tablet, 20 mEq extended-release tablet, 1.5 g/1.54 g oral solution
- Macleods: 750 mg extended-release tablet
- Major: 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet (NDC 00904-7547-61), 750 mg extended-release tablet (NDC 00904-7216-61), 1500 mg extended-release tablet
- Marlex Pharmaceuticals, Inc.: 1.5 g/1.58 g oral solution
- Marlex Pharmaceuticals Inc: 1.5 g/1.58 g oral solution, 3 g/4.75 g oral solution
- Mylan: 8 mEq extended-release tablet, 10 mEq extended-release tablet
- NCS HealthCare of KY, LLC dba Vangard: 750 mg extended-release tablet (NDC 00615-8399-05), 750 mg extended-release tablet (NDC 00615-8570-05), 1500 mg extended-release tablet
- Northstar Rx: 750 mg extended-release capsule, 750 mg extended-release tablet, 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Northwind Health: 750 mg extended-release tablet (NDC 82868-0027-90), 750 mg extended-release tablet (NDC 82868-0111-90), 750 mg extended-release tablet (NDC 51655-0706-52), 750 mg extended-release tablet (NDC 51655-0226-26), 750 mg extended-release tablet (NDC 51655-0463-84), 1500 mg extended-release tablet
- Novel: 1.5 g/1.54 g oral solution
- PAI Holdings, LLC dba PAI: 20 mEq/15 mL oral solution (NDC 00121-0948-16), 20 mEq/15 mL oral solution (NDC 00121-4948-00), 20 mEq/30 mL oral solution, 40 mEq/15 mL oral solution
- PD-Rx: 600 mg extended-release capsule, 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet, 1500 mg extended-release tablet
- Preferred: 1500 mg extended-release tablet
- Proficient Rx: 750 mg extended-release tablet (NDC 82804-0109-30), 750 mg extended-release tablet (NDC 82804-0187-30), 1500 mg extended-release tablet (NDC 71205-0824-03), 1500 mg extended-release tablet (NDC 82804-0057-30)
- Redpharm Drug: 1500 mg extended-release tablet (NDC 67296-2131-02), 1500 mg extended-release tablet (NDC 67296-2160-01), 1500 mg extended-release tablet (NDC 67296-2243-06)
- Remedyrepack: 750 mg extended-release tablet (NDC 70518-3024-01), 750 mg extended-release tablet (NDC 70518-4095-02), 750 mg extended-release tablet (NDC 70518-4520-00), 750 mg extended-release tablet (NDC 70518-2964-00), 1500 mg extended-release tablet
- Rising: 600 mg extended-release tablet, 750 mg extended-release tablet
- Slate Run: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 70436-0002-01), 750 mg extended-release tablet (NDC 70436-0152-01)
- Solco Healthcare: 750 mg tablet, 1125 mg tablet
- Somerset Therapeutics: 1.5 g/1.58 g oral solution
- St. Mary's Medical Park Pharmacy: 750 mg extended-release tablet
- Strides Pharma Science: 600 mg extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Sun: 600 mg extended-release capsule, 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet
- Upsher-Smith: 600 mg extended-release tablet (NDC 24979-0229-00), 600 mg extended-release tablet (NDC 00245-0835-11), 600 mg extended-release tablet (NDC 00245-5315-01), 600 mg extended-release tablet (NDC 00832-5322-10), 750 mg extended-release tablet (NDC 24979-0231-01), 750 mg extended-release tablet (NDC 24979-0230-00), 750 mg extended-release tablet (NDC 00245-5317-01), 750 mg extended-release tablet (NDC 00245-0836-11), 750 mg extended-release tablet (NDC 00245-5316-01), 750 mg extended-release tablet (NDC 00832-5323-10), 1125 mg extended-release tablet, 1500 mg extended-release tablet (NDC 24979-0232-01), 1500 mg extended-release tablet (NDC 00245-5319-01), 1.5 g oral solution
- Upsher-SmithLaboratories: 750 mg extended-release tablet, 1500 mg extended-release tablet
- XLCare: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus: 750 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus Lifesciences: 750 mg extended-release tablet
Lists propylene glycol
- A-S Medication Solutions: 10 mEq extended-release capsule, 750 mg extended-release capsule
- Advagen Pharma Limited: 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Ajenat: 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- American Health Packaging: 1.5 g/15 mL oral solution (NDC 60687-0628-07), 1.5 g/15 mL oral solution (NDC 60687-0884-07)
- Amneal Pharmaceuticals NY LLC: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Atlantic Biologicals: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Aurobindo: 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- AvPAK: 3 g/15 mL oral solution
- BluePoint: 750 mg extended-release capsule
- BPI: 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Camber: 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Cardinal Health 107: 1.5 g/15 mL oral solution
- Granules India: 600 mg extended-release capsule, 750 mg extended-release capsule
- Granules Pharmaceuticals Inc: 600 mg extended-release capsule, 750 mg extended-release capsule
- Granules Pharmaceuticals Inc.: 20 mEq/15 mL oral solution
- Kesin: 1.5 g/15 mL oral solution, 3 g/30 mL oral solution
- Lupin Pharmaceuticals, Inc.: 10 mEq extended-release capsule
- Lupin Pharmaceuticals,Inc.: 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Macleods: 20 mEq/15 mL oral solution
- Major: 20 mEq/15 mL oral solution, 40 mEq/30 mL oral solution
- NCS HealthCare of KY, LLC dba Vangard: 750 mg extended-release capsule
- Remedyrepack: 750 mg extended-release capsule
- Saptalis: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Solco Healthcare: 600 mg extended-release capsule, 750 mg extended-release capsule
- Tris: 20 mEq/15 mL oral solution
- Zydus: 600 mg extended-release capsule, 750 mg extended-release capsule
Potassium Chloride without polyethylene glycol or polysorbate
Polyethylene glycol or polysorbate: PEG, macrogol or polysorbate; a rare cause of allergic reactions. 72 of 262 checked products list polyethylene glycol or polysorbate; 190 do not.
Does not list polyethylene glycol or polysorbate
- A-S Medication Solutions: 10 mEq extended-release capsule, 750 mg extended-release capsule, 1500 mg extended-release tablet (NDC 50090-5665-00), 1500 mg extended-release tablet (NDC 50090-6253-00), 1500 mg extended-release tablet (NDC 50090-6866-00), 1500 mg extended-release tablet (NDC 50090-6867-00), 1500 mg extended-release tablet (NDC 50090-7192-00), 1500 mg extended-release tablet (NDC 50090-7193-00), 1500 mg extended-release tablet (NDC 50090-7456-00), 1500 mg extended-release tablet (NDC 50090-7616-00)
- Actavis: 750 mg extended-release capsule, 20 mEq extended-release tablet
- Adare: 600 mg capsule, 750 mg capsule
- Advagen Pharma Limited: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Advagen Pharma Ltd.: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Ajenat: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- American Health Packaging: 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet, 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution (NDC 60687-0628-07), 1.5 g/15 mL oral solution (NDC 60687-0884-07)
- Amneal Pharmaceuticals LLC: 1.5 g/1.58 g oral solution
- Amneal Pharmaceuticals NY LLC: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Amneal Pharmaceuticals of New York: 750 mg extended-release capsule
- ANI: 1.5 g/1.56 g oral solution
- Aphena Pharma Solutions - Tennessee: 1500 mg extended-release tablet
- Atlantic Biologicals: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Aurobindo: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- AvKARE: 750 mg extended-release capsule, 1500 mg extended-release tablet
- AvPAK: 750 mg extended-release capsule, 3 g/15 mL oral solution
- B. Braun Medical: 14.9 g/100 mL injection
- Baxter Healthcare: 7.46 g/1000 mL injection, 14.9 g/1000 mL injection, 29.8 g/1000 mL injection
- BluePoint: 750 mg extended-release capsule (NDC 68001-0396-00), 750 mg extended-release capsule (NDC 68001-0619-00)
- Bluepoint: 750 mg tablet, 1500 mg tablet
- BPI: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Bryant Ranch Prepack: 600 mg extended-release capsule, 750 mg extended-release tablet (NDC 63629-1072-01), 750 mg extended-release tablet (NDC 63629-1073-01), 750 mg extended-release tablet (NDC 63629-1074-01), 750 mg extended-release tablet (NDC 63629-1075-01), 750 mg extended-release tablet (NDC 71335-1900-01), 750 mg extended-release tablet (NDC 71335-2503-01), 750 mg extended-release tablet (NDC 71335-2607-01), 750 mg extended-release tablet (NDC 71335-2866-01), 750 mg extended-release tablet (NDC 71335-2913-01), 750 mg extended-release tablet (NDC 71335-2958-01), 750 mg extended-release tablet (NDC 72162-1786-00), 1500 mg extended-release tablet (NDC 71335-1896-01), 1500 mg extended-release tablet (NDC 71335-1109-01), 1500 mg extended-release tablet (NDC 71335-1747-01), 1500 mg extended-release tablet (NDC 71335-2045-01), 1.5 g/1.77 g oral solution
- Camber: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Cardinal Health 107: 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution
- Carwin Pharmaceutical Associates: 0.75 g/0.79 g oral solution, 1.125 g/1.185 g oral solution, 10 mEq/15 mL oral solution
- Direct_Rx: 750 mg extended-release tablet, 1500 mg extended-release tablet
- Endo: 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Epic: 1.5 g/1.77 g oral solution
- Fresenius Kabi: 2 mEq/mL injection (NDC 63323-0965-05), 2 mEq/mL injection (NDC 63323-0967-30), 10 mEq/50 mL injection, 10 mEq/100 mL injection, 20 mEq/50 mL injection, 20 mEq/100 mL injection, 40 mEq/100 mL injection
- Genus Lifesciences: 20 mEq/15 mL oral solution
- Genus Lifesciences Inc.: 1.5 g/1.58 g oral solution
- Glenmark: 750 mg extended-release capsule
- Granules India: 600 mg extended-release capsule, 750 mg extended-release capsule, 750 mg tablet, 1500 mg tablet
- Granules Pharmaceuticals Inc: 600 mg extended-release capsule, 750 mg extended-release capsule
- Granules Pharmaceuticals Inc.: 750 mg extended-release tablet, 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution, 20 mEq/15 mL oral solution
- Guardian Drug: 1.5 g/1.57 g oral solution
- Henry Schein: 2 mEq/mL injection, 149 mg/mL injection
- Heritage Pharmaceuticals Inc. d/b/a Avet: 1.5 g/1.58 g oral solution
- HF Acquisition Co LLC, DBA HealthFirst: 149 mg/mL injection (NDC 51662-1421-01), 149 mg/mL injection (NDC 51662-1387-01)
- Hospira: 149 mg/mL injection (NDC 00409-6635-01), 149 mg/mL injection (NDC 00409-6651-06)
- ICU Medical: 10 mEq/100 mL injection, 200 mEq/1000 mL injection, 400 mEq/1000 mL injection
- IPG: 3 g/3.16 g oral solution
- Kesin: 1.5 g/1.58 g oral solution, 1.5 g/15 mL oral solution, 3 g/30 mL oral solution
- Lupin Pharmaceuticals, Inc.: 10 mEq extended-release capsule
- Lupin Pharmaceuticals,Inc.: 10 mEq extended-release tablet, 20 mEq extended-release tablet, 1.5 g/1.54 g oral solution, 20 mEq/15 mL oral solution, 40 mEq/15 mL oral solution
- Macleods: 20 mEq/15 mL oral solution
- Major: 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet, 1500 mg extended-release tablet, 20 mEq/15 mL oral solution, 40 mEq/30 mL oral solution
- Marlex Pharmaceuticals, Inc.: 1.5 g/1.58 g oral solution
- Marlex Pharmaceuticals Inc: 1.5 g/1.58 g oral solution, 3 g/4.75 g oral solution
- NCS HealthCare of KY, LLC dba Vangard: 750 mg extended-release capsule, 750 mg extended-release tablet, 1500 mg extended-release tablet
- Northstar Rx: 750 mg extended-release capsule, 750 mg extended-release tablet, 1500 mg extended-release tablet, 1.5 g/1.58 g oral solution
- Northwind Health: 750 mg extended-release tablet, 1500 mg extended-release tablet
- Novel: 1.5 g/1.54 g oral solution
- PAI Holdings, LLC dba PAI: 20 mEq/15 mL oral solution (NDC 00121-0948-16), 20 mEq/15 mL oral solution (NDC 00121-4948-00), 20 mEq/30 mL oral solution, 40 mEq/15 mL oral solution
- PD-Rx: 600 mg extended-release capsule, 750 mg extended-release capsule, 20 mEq extended-release tablet
- Preferred: 1500 mg extended-release tablet
- Proficient Rx: 750 mg extended-release tablet, 1500 mg extended-release tablet
- Redpharm Drug: 1500 mg extended-release tablet (NDC 67296-2131-02), 1500 mg extended-release tablet (NDC 67296-2160-01), 1500 mg extended-release tablet (NDC 67296-2243-06)
- Remedyrepack: 750 mg extended-release capsule, 750 mg extended-release tablet (NDC 70518-3024-01), 750 mg extended-release tablet (NDC 70518-4095-02), 1500 mg extended-release tablet
- Saptalis: 1.5 g/15 mL oral solution, 3 g/15 mL oral solution
- Solco Healthcare: 600 mg extended-release capsule, 750 mg extended-release capsule, 750 mg tablet, 1125 mg tablet
- Somerset Therapeutics: 1.5 g/1.58 g oral solution
- Strides Pharma Science: 1.5 g/1.58 g oral solution
- Sun: 600 mg extended-release capsule, 750 mg extended-release capsule, 20 mEq extended-release tablet, 750 mg extended-release tablet
- Tris: 20 mEq/15 mL oral solution
- Upsher-Smith: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet, 1.5 g oral solution
- Upsher-SmithLaboratories: 750 mg extended-release tablet, 1500 mg extended-release tablet
- XLCare: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
Lists polyethylene glycol or polysorbate
- A-S Medication Solutions: 10 mEq extended-release tablet, 750 mg extended-release tablet (NDC 50090-6639-00), 750 mg extended-release tablet (NDC 50090-6640-00), 750 mg extended-release tablet (NDC 50090-5335-00), 750 mg extended-release tablet (NDC 50090-7378-00), 750 mg extended-release tablet (NDC 50090-7379-00), 750 mg extended-release tablet (NDC 50090-7639-00), 750 mg extended-release tablet (NDC 50090-7640-00), 750 mg extended-release tablet (NDC 50090-7748-00), 750 mg extended-release tablet (NDC 50090-7749-00)
- Advagen Pharma Ltd: 750 mg extended-release tablet, 1125 mg extended-release tablet, 1500 mg extended-release tablet
- Aphena Pharma Solutions - Tennessee: 750 mg extended-release tablet (NDC 71610-0977-30), 750 mg extended-release tablet (NDC 71610-0935-60), 750 mg extended-release tablet (NDC 71610-0932-60), 750 mg extended-release tablet (NDC 71610-0960-60), 750 mg extended-release tablet (NDC 71610-0945-30), 750 mg extended-release tablet (NDC 71610-0944-30), 750 mg extended-release tablet (NDC 71610-0349-15)
- Aurobindo: 600 mg extended-release tablet, 750 mg extended-release tablet
- AvKARE: 750 mg extended-release tablet (NDC 42291-0487-01), 750 mg extended-release tablet (NDC 42291-0506-01)
- BluePoint: 750 mg extended-release tablet
- Bryant Ranch Prepack: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 71335-1131-01), 750 mg extended-release tablet (NDC 71335-2447-01)
- Coupler: 750 mg extended-release tablet
- Direct_Rx: 750 mg extended-release tablet
- Epic: 600 mg extended-release tablet, 750 mg extended-release tablet
- Granules Pharmaceuticals Inc.: 600 mg extended-release tablet, 750 mg extended-release tablet
- Macleods: 750 mg extended-release tablet
- Major: 750 mg extended-release tablet
- Mylan: 8 mEq extended-release tablet, 10 mEq extended-release tablet
- NCS HealthCare of KY, LLC dba Vangard: 750 mg extended-release tablet
- Northwind Health: 750 mg extended-release tablet (NDC 82868-0111-90), 750 mg extended-release tablet (NDC 51655-0706-52), 750 mg extended-release tablet (NDC 51655-0226-26), 750 mg extended-release tablet (NDC 51655-0463-84)
- PD-Rx: 750 mg extended-release tablet, 1500 mg extended-release tablet
- Proficient Rx: 750 mg extended-release tablet, 1500 mg extended-release tablet
- Remedyrepack: 750 mg extended-release tablet (NDC 70518-4520-00), 750 mg extended-release tablet (NDC 70518-2964-00)
- Rising: 600 mg extended-release tablet, 750 mg extended-release tablet
- Slate Run: 600 mg extended-release tablet, 750 mg extended-release tablet (NDC 70436-0002-01), 750 mg extended-release tablet (NDC 70436-0152-01)
- St. Mary's Medical Park Pharmacy: 750 mg extended-release tablet
- Strides Pharma Science: 600 mg extended-release tablet, 750 mg extended-release tablet
- Upsher-Smith: 600 mg extended-release tablet (NDC 24979-0229-00), 600 mg extended-release tablet (NDC 00245-0835-11), 600 mg extended-release tablet (NDC 00245-5315-01), 600 mg extended-release tablet (NDC 00832-5322-10), 750 mg extended-release tablet (NDC 24979-0231-01), 750 mg extended-release tablet (NDC 24979-0230-00), 750 mg extended-release tablet (NDC 00245-0836-11), 750 mg extended-release tablet (NDC 00245-5316-01), 750 mg extended-release tablet (NDC 00832-5323-10), 1500 mg extended-release tablet
- Zydus: 600 mg extended-release capsule, 750 mg extended-release capsule, 750 mg extended-release tablet, 1500 mg extended-release tablet
- Zydus Lifesciences: 750 mg extended-release tablet
At the pharmacy counter
How to use this at the pharmacy counter
- Pick the company whose list suits you and copy the NDC from the table. Many pharmacies order from wholesalers that carry several companies' versions and can request a particular one if you ask before the prescription is filled; some buy from one contracted source only, and a few insurance plans cover only certain NDCs, so ask the pharmacist to check.
- Treat "does not list" as exactly that. The label is what the manufacturer declared; a flavor or a starch may have an unstated source, and lines change. For celiac disease or a serious allergy, ask the manufacturer's medical information line for a written statement about the lot you have.
- Check the bottle each refill. A different company usually means a different shape, color and inactive-ingredient list; the pharmacist can tell you who made it, and the two-NDC comparison shows the difference line by line.
- If you need one company's version kept constant, ask your prescriber to write that company or the NDC on the prescription and tell the pharmacy you need it held. Rules vary by state and plan, so confirm with the pharmacist.
Common questions about Potassium Chloride inactive ingredients
Is Potassium Chloride gluten-free?
Does Potassium Chloride contain lactose?
Does Potassium Chloride contain soy?
Is there a dye-free Potassium Chloride?
Does Potassium Chloride contain gelatin?
Why do the inactive ingredients differ between manufacturers?
Can my pharmacy give me a specific manufacturer's version?
How current is this list?
Sources: the products are the finished Potassium Chloride products in the FDA's current NDC directory (openFDA), as of October 6, 2026; each inactive-ingredient list is the manufacturer's FDA Structured Product Label via DailyMed, as our label sync last read it. The concern groups are HelloPharmacist's classification of the names the label declares. Educational information only, not medical advice; confirm with your pharmacist before relying on a list. ← Back to the Potassium Chloride guide